{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T23:10:40Z","timestamp":1793833840642,"version":"4.6.1"},"reference-count":325,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T00:00:00Z","timestamp":1692230400000},"content-version":"vor","delay-in-days":685,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1007\/s13311-021-01145-z","type":"journal-article","created":{"date-parts":[[2021,11,8]],"date-time":"2021-11-08T18:02:15Z","timestamp":1636394535000},"page":"2236-2268","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":57,"title":["Mechanisms and Treatments in Demyelinating CMT"],"prefix":"10.1016","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0068-8549","authenticated-orcid":false,"given":"Vera","family":"Fridman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario A.","family":"Saporta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1007\/s13311-021-01145-z_bib1","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/j.1399-0004.1974.tb00638.x","article-title":"Genetic and clinical aspects of Charcot-Marie-Tooth's disease","volume":"6","author":"Skre","year":"1974","journal-title":"Clin Genet."},{"issue":"2","key":"10.1007\/s13311-021-01145-z_bib2","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1093\/brain\/103.2.259","article-title":"The clinical features of hereditary motor and sensory neuropathy types I and II","volume":"103","author":"Harding","year":"1980","journal-title":"Brain."},{"issue":"10","key":"10.1007\/s13311-021-01145-z_bib3","doi-asserted-by":"crossref","first-page":"e870","DOI":"10.1212\/WNL.0000000000005074","article-title":"Updating the classification of inherited neuropathies: Results of an international survey","volume":"90","author":"Magy","year":"2018","journal-title":"Neurology."},{"issue":"10","key":"10.1007\/s13311-021-01145-z_bib4","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1111\/ene.13079","article-title":"Nerve conduction velocity in CMT1A: what else can we tell?","volume":"23","author":"Manganelli","year":"2016","journal-title":"Eur J Neurol."},{"issue":"8","key":"10.1007\/s13311-021-01145-z_bib5","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/acn3.432","article-title":"Caveats in the Established Understanding of CMT1A","volume":"4","author":"Li","year":"2017","journal-title":"Ann Clin Transl Neurol."},{"issue":"4","key":"10.1007\/s13311-021-01145-z_bib6","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1212\/WNL.50.4.1061","article-title":"Charcot-Marie-Tooth disease type 1A with 17p duplication in infancy and early childhood: a longitudinal clinical and electrophysiologic study","volume":"50","author":"Garcia","year":"1998","journal-title":"Neurology."},{"issue":"1","key":"10.1007\/s13311-021-01145-z_bib7","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.1212\/WNL.0000000000008672","article-title":"Targeted next-generation sequencing panels in the diagnosis of Charcot-Marie-Tooth disease","volume":"94","author":"Cortese","year":"2020","journal-title":"Neurology."},{"issue":"5","key":"10.1007\/s13311-021-01145-z_bib8","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/jnc.14217","article-title":"Frequent genes in rare diseases: panel-based next generation sequencing to disclose causal mutations in hereditary neuropathies","volume":"143","author":"Dohrn","year":"2017","journal-title":"J Neurochem."},{"issue":"1","key":"10.1007\/s13311-021-01145-z_bib9","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/ana.22166","article-title":"Charcot-Marie-Tooth disease subtypes and genetic testing strategies","volume":"69","author":"Saporta","year":"2011","journal-title":"Ann Neurol."},{"issue":"1","key":"10.1007\/s13311-021-01145-z_bib10","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1136\/jnnp-2018-318834","article-title":"Challenges in modelling the Charcot-Marie-Tooth neuropathies for therapy development","volume":"90","author":"Juneja","year":"2019","journal-title":"J Neurol Neurosurg Psychiatry."},{"issue":"5","key":"10.1007\/s13311-021-01145-z_bib11","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1002\/humu.23412","article-title":"Variant pathogenicity evaluation in the community-driven Inherited Neuropathy Variant Browser","volume":"39","author":"Saghira","year":"2018","journal-title":"Hum Mutat."},{"issue":"2","key":"10.1007\/s13311-021-01145-z_bib12","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/j.1085-9489.2006.00080.x","article-title":"SIMPLE mutation analysis in dominant demyelinating Charcot-Marie-Tooth disease: three novel mutations","volume":"11","author":"Latour","year":"2006","journal-title":"J Peripher Nerv Syst."},{"issue":"7","key":"10.1007\/s13311-021-01145-z_bib13","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1136\/jnnp-2012-302451","article-title":"Charcot-Marie-Tooth disease: frequency of genetic subtypes and guidelines for genetic testing","volume":"83","author":"Murphy","year":"2012","journal-title":"J Neurol Neurosurg Psychiatry."},{"issue":"8","key":"10.1007\/s13311-021-01145-z_bib14","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1136\/jnnp-2014-308826","article-title":"CMT subtypes and disease burden in patients enrolled in the Inherited Neuropathies Consortium natural history study: a cross-sectional analysis","volume":"86","author":"Fridman","year":"2015","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"10.1007\/s13311-021-01145-z_bib15","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.neulet.2015.01.059","article-title":"Demyelinating CMT\u2013what's known, what's new and what's in store?","volume":"596","author":"Brennan","year":"2015","journal-title":"Neurosci Lett."},{"issue":"4","key":"10.1007\/s13311-021-01145-z_bib16","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.bbadis.2014.07.031","article-title":"Hereditary motor and sensory neuropathies: Understanding molecular pathogenesis could lead to future treatment strategies","volume":"1852","author":"Jerath","year":"2015","journal-title":"Biochim Biophys Acta."},{"issue":"18","key":"10.1007\/s13311-021-01145-z_bib17","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1056\/NEJMoa1702752","article-title":"Nusinersen versus Sham Control in Infantile-Onset Spinal Muscular Atrophy","volume":"377","author":"Finkel","year":"2017","journal-title":"N Engl J Med."},{"issue":"1","key":"10.1007\/s13311-021-01145-z_bib18","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1056\/NEJMoa1716793","article-title":"Inotersen Treatment for Patients with Hereditary Transthyretin Amyloidosis","volume":"379","author":"Benson","year":"2018","journal-title":"N Engl J Med."},{"issue":"1","key":"10.1007\/s13311-021-01145-z_bib19","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1172\/JCI96499","article-title":"PMP22 antisense oligonucleotides reverse Charcot-Marie-Tooth disease type 1A features in rodent models","volume":"128","author":"Zhao","year":"2018","journal-title":"J Clin Invest."},{"issue":"5","key":"10.1007\/s13311-021-01145-z_bib20","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/S0959-4388(02)00370-7","article-title":"Development of nodes of Ranvier","volume":"12","author":"Girault","year":"2002","journal-title":"Curr Opin Neurobiol."},{"issue":"7399","key":"10.1007\/s13311-021-01145-z_bib21","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/nature11007","article-title":"Glycolytic oligodendrocytes maintain myelin and long-term axonal integrity","volume":"485","author":"Funfschilling","year":"2012","journal-title":"Nature."},{"issue":"1\u20132","key":"10.1007\/s13311-021-01145-z_bib22","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1385\/NMM:8:1-2:217","article-title":"Pathomechanisms of mutant proteins in Charcot-Marie-Tooth disease","volume":"8","author":"Niemann","year":"2006","journal-title":"Neuromolecular Med."},{"issue":"1","key":"10.1007\/s13311-021-01145-z_bib23","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/(SICI)1098-1004(1996)7:1<36::AID-HUMU5>3.0.CO;2-N","article-title":"Myelin protein zero (MPZ) gene mutations in nonduplication type 1 Charcot-Marie-Tooth disease","volume":"7","author":"Roa","year":"1996","journal-title":"Hum Mutat."},{"issue":"11","key":"10.1007\/s13311-021-01145-z_bib24","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1007\/s00415-019-09453-3","article-title":"Mutation update for myelin protein zero-related neuropathies and the increasing role of variants causing a late-onset phenotype","volume":"266","author":"Callegari","year":"2019","journal-title":"J Neurol."},{"issue":"3","key":"10.1007\/s13311-021-01145-z_bib25","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/jns5.12040","article-title":"Two novel MPZ mutations in Chinese CMT patients","volume":"18","author":"Liu","year":"2013","journal-title":"J Peripher Nerv Syst."},{"issue":"1","key":"10.1007\/s13311-021-01145-z_bib26","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0896-6273(88)90211-5","article-title":"Isolation and analysis of the gene encoding peripheral myelin protein zero","volume":"1","author":"Lemke","year":"1988","journal-title":"Neuron."},{"issue":"3","key":"10.1007\/s13311-021-01145-z_bib27","first-page":"472","article-title":"Prevalence and origin of de novo duplications in Charcot-Marie-Tooth disease type 1A: first report of a de novo duplication with a maternal origin","volume":"58","author":"Blair","year":"1996","journal-title":"Am J Hum Genet."},{"issue":"3","key":"10.1007\/s13311-021-01145-z_bib28","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1002\/mus.24169","article-title":"Pain and small fiber function in Charcot-Marie-Tooth disease type 1A","volume":"50","author":"Laura","year":"2014","journal-title":"Muscle Nerve."},{"issue":"5","key":"10.1007\/s13311-021-01145-z_bib29","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1097\/WCO.0000000000000601","article-title":"Nerve and skin biopsy in neuropathies","volume":"31","author":"Sommer","year":"2018","journal-title":"Curr Opin Neurol."},{"issue":"Pt 7","key":"10.1007\/s13311-021-01145-z_bib30","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1093\/brain\/123.7.1516","article-title":"Neurological dysfunction and axonal degeneration in Charcot-Marie-Tooth disease type 1A","volume":"123","author":"Krajewski","year":"2000","journal-title":"Brain."},{"issue":"7","key":"10.1007\/s13311-021-01145-z_bib31","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/S1474-4422(09)70110-3","article-title":"Diagnosis, natural history, and management of Charcot-Marie-Tooth disease","volume":"8","author":"Pareyson","year":"2009","journal-title":"Lancet Neurol."},{"key":"10.1007\/s13311-021-01145-z_bib32","doi-asserted-by":"crossref","unstructured":"Fabrizi GM, Simonati A, Morbin M, Cavallaro T, Taioli F, Benedetti MD, et al. Clinical and pathological correlations in Charcot-Marie-Tooth neuropathy type 1A with the 17p11.2p12 duplication: a cross-sectional morphometric and immunohistochemical study in twenty cases. Muscle Nerve. 1998;21(7):869\u201377.","DOI":"10.1002\/(SICI)1097-4598(199807)21:7<869::AID-MUS4>3.0.CO;2-4"},{"key":"10.1007\/s13311-021-01145-z_bib33","doi-asserted-by":"crossref","unstructured":"Thomas PK, Marques W, Jr., Davis MB, Sweeney MG, King RH, Bradley JL, et al. The phenotypic manifestations of chromosome 17p11.2 duplication. Brain. 1997;120 ( Pt 3):465\u201378.","DOI":"10.1093\/brain\/120.3.465"},{"issue":"3","key":"10.1007\/s13311-021-01145-z_bib34","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.1529-8027.2008.00182.x","article-title":"Neurophysiologic abnormalities in children with Charcot-Marie-Tooth disease type 1A","volume":"13","author":"Yiu","year":"2008","journal-title":"J Peripher Nerv Syst."},{"issue":"Pt 12","key":"10.1007\/s13311-021-01145-z_bib35","doi-asserted-by":"crossref","first-page":"3263","DOI":"10.1093\/brain\/awp274","article-title":"Shortened internodal length of dermal myelinated nerve fibres in Charcot-Marie-Tooth disease type 1A","volume":"132","author":"Saporta","year":"2009","journal-title":"Brain."},{"issue":"2","key":"10.1007\/s13311-021-01145-z_bib36","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s12035-012-8370-x","article-title":"The PMP22 gene and its related diseases","volume":"47","author":"Li","year":"2013","journal-title":"Mol Neurobiol."},{"issue":"2","key":"10.1007\/s13311-021-01145-z_bib37","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3233\/JND-190377","article-title":"Modifier Gene Candidates in Charcot-Marie-Tooth Disease Type 1A: A Case-Only Genome-Wide Association Study","volume":"6","author":"Tao","year":"2019","journal-title":"J Neuromuscul Dis."},{"issue":"4","key":"10.1007\/s13311-021-01145-z_bib38","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1055\/s-0035-1558981","article-title":"Inherited Neuropathies","volume":"35","author":"Fridman","year":"2015","journal-title":"Semin Neurol."},{"issue":"Pt 7","key":"10.1007\/s13311-021-01145-z_bib39","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1093\/brain\/awp113","article-title":"PMP22 expression in dermal nerve myelin from patients with CMT1A","volume":"132","author":"Katona","year":"2009","journal-title":"Brain."},{"issue":"1","key":"10.1007\/s13311-021-01145-z_bib40","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0092-8674(93)90058-X","article-title":"DNA deletion associated with hereditary neuropathy with liability to pressure palsies","volume":"72","author":"Chance","year":"1993","journal-title":"Cell."},{"issue":"3","key":"10.1007\/s13311-021-01145-z_bib41","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/ng1195-226","article-title":"Myelin genes: getting the dosage right","volume":"11","author":"Scherer","year":"1995","journal-title":"Nat Genet."},{"issue":"1","key":"10.1007\/s13311-021-01145-z_bib42","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s13052-017-0414-4","article-title":"Hereditary neuropathy with liability to pressure palsy (HNPP): report of a family with a new point mutation in PMP22 gene","volume":"43","author":"Fusco","year":"2017","journal-title":"Ital J Pediatr."},{"issue":"Pt 5","key":"10.1007\/s13311-021-01145-z_bib43","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1093\/brain\/123.5.1001","article-title":"Mutation-dependent alteration in cellular distribution of peripheral myelin protein 22 in nerve biopsies from Charcot-Marie-Tooth type 1A","volume":"123","author":"Hanemann","year":"2000","journal-title":"Brain."},{"issue":"12","key":"10.1007\/s13311-021-01145-z_bib44","doi-asserted-by":"crossref","first-page":"4662","DOI":"10.1523\/JNEUROSCI.17-12-04662.1997","article-title":"Heterozygous peripheral myelin protein 22-deficient mice are affected by a progressive demyelinating tomaculous neuropathy","volume":"17","author":"Adlkofer","year":"1997","journal-title":"J Neurosci."},{"issue":"1","key":"10.1007\/s13311-021-01145-z_bib45","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1083\/jcb.117.1.225","article-title":"Characterization of a novel peripheral nervous system myelin protein (PMP-22\/SR13)","volume":"117","author":"Snipes","year":"1992","journal-title":"J Cell Biol."},{"issue":"48","key":"10.1007\/s13311-021-01145-z_bib46","doi-asserted-by":"crossref","first-page":"16140","DOI":"10.1523\/JNEUROSCI.1908-14.2014","article-title":"PMP22 is critical for actin-mediated cellular functions and for establishing lipid rafts","volume":"34","author":"Lee","year":"2014","journal-title":"J Neurosci."},{"key":"10.1007\/s13311-021-01145-z_bib47","doi-asserted-by":"crossref","unstructured":"Mittendorf KF, Marinko JT, Hampton CM, Ke Z, Hadziselimovic A, Schlebach JP, et al. Peripheral myelin protein 22 alters membrane architecture. Sci Adv. 2017;3(7):e1700220.","DOI":"10.1126\/sciadv.1700220"},{"issue":"2","key":"10.1007\/s13311-021-01145-z_bib48","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/jnr.490400202","article-title":"Peripheral myelin protein 22: facts and hypotheses","volume":"40","author":"Suter","year":"1995","journal-title":"J Neurosci Res."},{"issue":"20","key":"10.1007\/s13311-021-01145-z_bib49","doi-asserted-by":"crossref","first-page":"7754","DOI":"10.1523\/JNEUROSCI.17-20-07754.1997","article-title":"Neurons promote the translocation of peripheral myelin protein 22 into myelin","volume":"17","author":"Pareek","year":"1997","journal-title":"J Neurosci."},{"issue":"3","key":"10.1007\/s13311-021-01145-z_bib50","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0301-0082(99)00049-0","article-title":"Myelin synthesis in the peripheral nervous system","volume":"61","author":"Garbay","year":"2000","journal-title":"Prog Neurobiol."},{"issue":"9","key":"10.1007\/s13311-021-01145-z_bib51","doi-asserted-by":"crossref","first-page":"3396","DOI":"10.1523\/JNEUROSCI.19-09-03396.1999","article-title":"Peripheral myelin protein 22 and protein zero: a novel association in peripheral nervous system myelin","volume":"19","author":"D'Urso","year":"1999","journal-title":"J Neurosci."},{"issue":"4","key":"10.1007\/s13311-021-01145-z_bib52","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.mcn.2004.06.009","article-title":"Peripheral myelin protein 22 kDa and protein zero: domain specific trans-interactions","volume":"27","author":"Hasse","year":"2004","journal-title":"Mol Cell Neurosci."},{"issue":"17","key":"10.1007\/s13311-021-01145-z_bib53","doi-asserted-by":"crossref","first-page":"5351","DOI":"10.1523\/JNEUROSCI.16-17-05351.1996","article-title":"Impaired differentiation of Schwann cells in transgenic mice with increased PMP22 gene dosage","volume":"16","author":"Magyar","year":"1996","journal-title":"J Neurosci."},{"key":"10.1007\/s13311-021-01145-z_bib54","first-page":"60","article-title":"Diagnosis and therapy of acute purulent destructive pneumonia in children (current state of the problem)","volume":"3","author":"Sergeev","year":"1977","journal-title":"Grudn Khir."},{"key":"10.1007\/s13311-021-01145-z_bib55","doi-asserted-by":"crossref","unstructured":"Pantera H, Shy ME, Svaren J. Regulating PMP22 expression as a dosage sensitive neuropathy gene. Brain Res. 2020;1726:146491.","DOI":"10.1016\/j.brainres.2019.146491"},{"issue":"4","key":"10.1007\/s13311-021-01145-z_bib56","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/nm1023","article-title":"Ascorbic acid treatment corrects the phenotype of a mouse model of Charcot-Marie-Tooth disease","volume":"10","author":"Passage","year":"2004","journal-title":"Nat Med."},{"key":"10.1007\/s13311-021-01145-z_bib57","doi-asserted-by":"crossref","unstructured":"Sereda MW, Meyer zu Horste G, Suter U, Uzma N, Nave KA. Therapeutic administration of progesterone antagonist in a model of Charcot-Marie-Tooth disease (CMT-1A). Nat Med. 2003;9(12):1533\u20137.","DOI":"10.1038\/nm957"},{"issue":"10","key":"10.1007\/s13311-021-01145-z_bib58","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1093\/hmg\/10.10.1007","article-title":"Induced myelination and demyelination in a conditional mouse model of Charcot-Marie-Tooth disease type 1A","volume":"10","author":"Perea","year":"2001","journal-title":"Hum Mol Genet."},{"issue":"3","key":"10.1007\/s13311-021-01145-z_bib59","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.ajhg.2014.01.017","article-title":"Mechanism, prevalence, and more severe neuropathy phenotype of the Charcot-Marie-Tooth type 1A triplication","volume":"94","author":"Liu","year":"2014","journal-title":"Am J Hum Genet."},{"issue":"15","key":"10.1007\/s13311-021-01145-z_bib60","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1212\/WNL.0000000000001470","article-title":"Genetic dosage compensation via co-occurrence of PMP22 duplication and PMP22 deletion","volume":"84","author":"Hirt","year":"2015","journal-title":"Neurology."},{"issue":"Pt 6","key":"10.1007\/s13311-021-01145-z_bib61","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1093\/brain\/awu071","article-title":"PMP22 messenger RNA levels in skin biopsies: testing the effectiveness of a Charcot-Marie-Tooth 1A biomarker","volume":"137","author":"Nobbio","year":"2014","journal-title":"Brain."},{"issue":"9","key":"10.1007\/s13311-021-01145-z_bib62","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1038\/nm.3664","article-title":"Soluble neuregulin-1 modulates disease pathogenesis in rodent models of Charcot-Marie-Tooth disease 1A","volume":"20","author":"Fledrich","year":"2014","journal-title":"Nat Med."},{"issue":"7","key":"10.1007\/s13311-021-01145-z_bib63","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1001\/archneur.64.7.974","article-title":"Stoichiometric alteration of PMP22 protein determines the phenotype of hereditary neuropathy with liability to pressure palsies","volume":"64","author":"Li","year":"2007","journal-title":"Arch Neurol."},{"key":"10.1007\/s13311-021-01145-z_bib64","doi-asserted-by":"crossref","unstructured":"Morena J, Gupta A, Hoyle JC. Charcot-Marie-Tooth: From Molecules to Therapy. Int J Mol Sci. 2019;20(14).","DOI":"10.3390\/ijms20143419"},{"issue":"41","key":"10.1007\/s13311-021-01145-z_bib65","doi-asserted-by":"crossref","first-page":"25795","DOI":"10.1016\/S0021-9258(18)47318-8","article-title":"Regulation of tissue-specific expression of alternative peripheral myelin protein-22 (PMP22) gene transcripts by two promoters","volume":"269","author":"Suter","year":"1994","journal-title":"J Biol Chem."},{"issue":"3","key":"10.1007\/s13311-021-01145-z_bib66","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S1044-7431(03)00246-X","article-title":"Distinct elements of the peripheral myelin protein 22 (PMP22) promoter regulate expression in Schwann cells and sensory neurons","volume":"24","author":"Maier","year":"2003","journal-title":"Mol Cell Neurosci."},{"issue":"1","key":"10.1007\/s13311-021-01145-z_bib67","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1006\/mcne.2002.1116","article-title":"Identification of the regulatory region of the peripheral myelin protein 22 (PMP22) gene that directs temporal and spatial expression in development and regeneration of peripheral nerves","volume":"20","author":"Maier","year":"2002","journal-title":"Mol Cell Neurosci."},{"issue":"16","key":"10.1007\/s13311-021-01145-z_bib68","doi-asserted-by":"crossref","first-page":"2830","DOI":"10.1093\/hmg\/ddy191","article-title":"Regulation of the neuropathy-associated Pmp22 gene by a distal super-enhancer","volume":"27","author":"Pantera","year":"2018","journal-title":"Hum Mol Genet."},{"issue":"10","key":"10.1007\/s13311-021-01145-z_bib69","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1093\/hmg\/ddaa082","article-title":"Pmp22 super-enhancer deletion causes tomacula formation and conduction block in peripheral nerves","volume":"29","author":"Pantera","year":"2020","journal-title":"Hum Mol Genet."},{"issue":"11","key":"10.1007\/s13311-021-01145-z_bib70","doi-asserted-by":"crossref","first-page":"4242","DOI":"10.1523\/JNEUROSCI.5893-10.2011","article-title":"Regulation of the PMP22 gene through an intronic enhancer","volume":"31","author":"Jones","year":"2011","journal-title":"J Neurosci."},{"issue":"14","key":"10.1007\/s13311-021-01145-z_bib71","first-page":"3055","article-title":"Tead1 regulates the expression of Peripheral Myelin Protein 22 during Schwann cell development","volume":"25","author":"Lopez-Anido","year":"2016","journal-title":"Hum Mol Genet."},{"issue":"26","key":"10.1007\/s13311-021-01145-z_bib72","doi-asserted-by":"crossref","first-page":"9620","DOI":"10.1523\/JNEUROSCI.0761-11.2011","article-title":"Interplay between LXR and Wnt\/beta-catenin signaling in the negative regulation of peripheral myelin genes by oxysterols","volume":"31","author":"Makoukji","year":"2011","journal-title":"J Neurosci."},{"issue":"4","key":"10.1007\/s13311-021-01145-z_bib73","first-page":"236","article-title":"microRNAs: a newly described class of encoded molecules that play a role in health and disease","volume":"14","author":"Felekkis","year":"2010","journal-title":"Hippokratia."},{"issue":"12","key":"10.1007\/s13311-021-01145-z_bib74","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1002\/glia.20846","article-title":"Peripheral myelin protein 22 is regulated post-transcriptionally by miRNA-29a","volume":"57","author":"Verrier","year":"2009","journal-title":"Glia."},{"issue":"11","key":"10.1007\/s13311-021-01145-z_bib75","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1016\/j.celrep.2017.08.064","article-title":"Changes in the Coding and Non-coding Transcriptome and DNA Methylome that Define the Schwann Cell Repair Phenotype after Nerve Injury","volume":"20","author":"Arthur-Farraj","year":"2017","journal-title":"Cell Rep."},{"issue":"2","key":"10.1007\/s13311-021-01145-z_bib76","doi-asserted-by":"crossref","first-page":"279","DOI":"10.5607\/en.2019.28.2.279","article-title":"miR-381 Attenuates Peripheral Neuropathic Phenotype Caused by Overexpression of PMP22","volume":"28","author":"Lee","year":"2019","journal-title":"Exp Neurobiol."},{"key":"10.1007\/s13311-021-01145-z_bib77","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1750-1172-9-38","article-title":"PMP22 related neuropathies: Charcot-Marie-Tooth disease type 1A and Hereditary Neuropathy with liability to Pressure Palsies","volume":"9","author":"van Paassen","year":"2014","journal-title":"Orphanet J Rare Dis."},{"issue":"3","key":"10.1007\/s13311-021-01145-z_bib78","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1002\/ana.25426","article-title":"Variation in SIPA1L2 is correlated with phenotype modification in Charcot- Marie- Tooth disease type 1A","volume":"85","author":"Tao","year":"2019","journal-title":"Ann Neurol."},{"issue":"1","key":"10.1007\/s13311-021-01145-z_bib79","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s10048-014-0426-9","article-title":"The LITAF\/SIMPLE I92V sequence variant results in an earlier age of onset of CMT1A\/HNPP diseases","volume":"16","author":"Sinkiewicz-Darol","year":"2015","journal-title":"Neurogenetics."},{"issue":"4","key":"10.1007\/s13311-021-01145-z_bib80","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1002\/ana.20434","article-title":"Early onset neuropathy in a compound form of Charcot-Marie-Tooth disease","volume":"57","author":"Meggouh","year":"2005","journal-title":"Ann Neurol."},{"issue":"19","key":"10.1007\/s13311-021-01145-z_bib81","doi-asserted-by":"crossref","first-page":"5171","DOI":"10.1093\/hmg\/ddu240","article-title":"Haplotype-specific modulation of a SOX10\/CREB response element at the Charcot-Marie-Tooth disease type 4C locus SH3TC2","volume":"23","author":"Brewer","year":"2014","journal-title":"Hum Mol Genet."},{"issue":"6","key":"10.1007\/s13311-021-01145-z_bib82","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.nmd.2018.04.002","article-title":"Association of miR-149 polymorphism with onset age and severity in Charcot-Marie-Tooth disease type 1A","volume":"28","author":"Nam","year":"2018","journal-title":"Neuromuscul Disord."},{"issue":"4","key":"10.1007\/s13311-021-01145-z_bib83","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/(SICI)1098-1136(19990215)25:4<358::AID-GLIA5>3.0.CO;2-K","article-title":"Temporal expression pattern of peripheral myelin protein 22 during in vivo and in vitro myelination","volume":"25","author":"Notterpek","year":"1999","journal-title":"Glia."},{"issue":"33","key":"10.1007\/s13311-021-01145-z_bib84","doi-asserted-by":"crossref","first-page":"10672","DOI":"10.1523\/JNEUROSCI.23-33-10672.2003","article-title":"Emerging role for autophagy in the removal of aggresomes in Schwann cells","volume":"23","author":"Fortun","year":"2003","journal-title":"J Neurosci."},{"issue":"2","key":"10.1007\/s13311-021-01145-z_bib85","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.nbd.2006.09.018","article-title":"The formation of peripheral myelin protein 22 aggregates is hindered by the enhancement of autophagy and expression of cytoplasmic chaperones","volume":"25","author":"Fortun","year":"2007","journal-title":"Neurobiol Dis."},{"issue":"1","key":"10.1007\/s13311-021-01145-z_bib86","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.nbd.2005.10.010","article-title":"Alterations in degradative pathways and protein aggregation in a neuropathy model based on PMP22 overexpression","volume":"22","author":"Fortun","year":"2006","journal-title":"Neurobiol Dis."},{"issue":"3","key":"10.1007\/s13311-021-01145-z_bib87","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.ajpath.2017.10.021","article-title":"Elevated Peripheral Myelin Protein 22, Reduced Mitotic Potential, and Proteasome Impairment in Dermal Fibroblasts from Charcot-Marie-Tooth Disease Type 1A Patients","volume":"188","author":"Lee","year":"2018","journal-title":"Am J Pathol."},{"issue":"1","key":"10.1007\/s13311-021-01145-z_bib88","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1073\/pnas.012593399","article-title":"Differential aggregation of the Trembler and Trembler J mutants of peripheral myelin protein 22","volume":"99","author":"Tobler","year":"2002","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"1","key":"10.1007\/s13311-021-01145-z_bib89","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrn1587","article-title":"Modulation of neurodegeneration by molecular chaperones","volume":"6","author":"Muchowski","year":"2005","journal-title":"Nat Rev Neurosci."},{"issue":"1","key":"10.1007\/s13311-021-01145-z_bib90","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.nbd.2008.06.015","article-title":"Pharmacological induction of the heat shock response improves myelination in a neuropathic model","volume":"32","author":"Rangaraju","year":"2008","journal-title":"Neurobiol Dis."},{"issue":"2","key":"10.1007\/s13311-021-01145-z_bib91","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1046\/j.1529-8027.2003.03017.x","article-title":"Evidence for impaired axonal regeneration in PMP22 duplication: studies in nerve xenografts","volume":"8","author":"Sahenk","year":"2003","journal-title":"J Peripher Nerv Syst."},{"key":"10.1007\/s13311-021-01145-z_bib92","doi-asserted-by":"crossref","unstructured":"Sahenk Z, Ozes B. Gene therapy to promote regeneration in Charcot-Marie-Tooth disease. Brain Res. 2020;1727:146533.","DOI":"10.1016\/j.brainres.2019.146533"},{"issue":"2","key":"10.1007\/s13311-021-01145-z_bib93","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.expneurol.2008.04.015","article-title":"Neurotrophin-3 deficient Schwann cells impair nerve regeneration","volume":"212","author":"Sahenk","year":"2008","journal-title":"Exp Neurol."},{"issue":"8","key":"10.1007\/s13311-021-01145-z_bib94","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1111\/j.1460-9568.2005.04052.x","article-title":"Neurotrophin-3 null mutant mice display a postnatal motor neuropathy","volume":"21","author":"Woolley","year":"2005","journal-title":"Eur J Neurosci."},{"issue":"5","key":"10.1007\/s13311-021-01145-z_bib95","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1212\/01.WNL.0000171978.70849.c5","article-title":"NT-3 promotes nerve regeneration and sensory improvement in CMT1A mouse models and in patients","volume":"65","author":"Sahenk","year":"2005","journal-title":"Neurology."},{"key":"10.1007\/s13311-021-01145-z_bib96","doi-asserted-by":"crossref","unstructured":"Yalvac ME, Amornvit J, Chen L, Shontz KM, Lewis S, Sahenk Z. AAV1.NT-3 gene therapy increases muscle fiber diameter through activation of mTOR pathway and metabolic remodeling in a CMT mouse model. Gene Ther. 2018;25(2):129\u201338.","DOI":"10.1038\/s41434-018-0009-8"},{"issue":"1","key":"10.1007\/s13311-021-01145-z_bib97","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.nbd.2004.02.007","article-title":"Impairment of PMP22 transgenic Schwann cells differentiation in culture: implications for Charcot-Marie-Tooth type 1A disease","volume":"16","author":"Nobbio","year":"2004","journal-title":"Neurobiol Dis."},{"issue":"4","key":"10.1007\/s13311-021-01145-z_bib98","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.neuron.2011.11.031","article-title":"A central role for the ERK-signaling pathway in controlling Schwann cell plasticity and peripheral nerve regeneration in vivo","volume":"73","author":"Napoli","year":"2012","journal-title":"Neuron."},{"issue":"4","key":"10.1007\/s13311-021-01145-z_bib99","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1177\/1535370218754492","article-title":"Soluble Neuregulin1 is strongly up-regulated in the rat model of Charcot-Marie-Tooth 1A disease","volume":"243","author":"Fornasari","year":"2018","journal-title":"Exp Biol Med (Maywood)."},{"issue":"34","key":"10.1007\/s13311-021-01145-z_bib100","doi-asserted-by":"crossref","first-page":"23146","DOI":"10.1074\/jbc.M109.027128","article-title":"P2X7-mediated increased intracellular calcium causes functional derangement in Schwann cells from rats with CMT1A neuropathy","volume":"284","author":"Nobbio","year":"2009","journal-title":"J Biol Chem."},{"issue":"1","key":"10.1007\/s13311-021-01145-z_bib101","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0022-510X(85)90034-6","article-title":"Vesicular demyelination induced by raised intracellular calcium","volume":"71","author":"Smith","year":"1985","journal-title":"J Neurol Sci."},{"issue":"5461","key":"10.1007\/s13311-021-01145-z_bib102","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1126\/science.287.5461.2267","article-title":"Response of Schwann cells to action potentials in development","volume":"287","author":"Stevens","year":"2000","journal-title":"Science."},{"issue":"32","key":"10.1007\/s13311-021-01145-z_bib103","doi-asserted-by":"crossref","first-page":"12054","DOI":"10.1074\/jbc.RA118.006248","article-title":"Peripheral myelin protein 22 modulates store-operated calcium channel activity, providing insights into Charcot-Marie-Tooth disease etiology","volume":"294","author":"Vanoye","year":"2019","journal-title":"J Biol Chem."},{"key":"10.1007\/s13311-021-01145-z_bib104","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.nbd.2016.07.017","article-title":"Tolerability and efficacy study of P2X7 inhibition in experimental Charcot-Marie-Tooth type 1A (CMT1A) neuropathy","volume":"95","author":"Sociali","year":"2016","journal-title":"Neurobiol Dis."},{"issue":"1","key":"10.1007\/s13311-021-01145-z_bib105","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.1038\/s41467-018-05420-0","article-title":"Targeting myelin lipid metabolism as a potential therapeutic strategy in a model of CMT1A neuropathy","volume":"9","author":"Fledrich","year":"2018","journal-title":"Nat Commun."},{"key":"10.1007\/s13311-021-01145-z_bib106","doi-asserted-by":"crossref","unstructured":"Fledrich R, Schlotter-Weigel B, Schnizer TJ, Wichert SP, Stassart RM, Meyer zu Horste G, et al. A rat model of Charcot-Marie-Tooth disease 1A recapitulates disease variability and supplies biomarkers of axonal loss in patients. Brain. 2012;135(Pt 1):72\u201387.","DOI":"10.1093\/brain\/awr322"},{"issue":"11","key":"10.1007\/s13311-021-01145-z_bib107","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1002\/glia.23840","article-title":"Subcellular diversion of cholesterol by gain- and loss-of-function mutations in PMP22","volume":"68","author":"Zhou","year":"2020","journal-title":"Glia."},{"issue":"2","key":"10.1007\/s13311-021-01145-z_bib108","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/j.1471-4159.1981.tb00451.x","article-title":"Lipid metabolism in peripheral nerve cell culture (rich in Schwann cells) from normal and trembler mice","volume":"37","author":"Bourre","year":"1981","journal-title":"J Neurochem."},{"issue":"5","key":"10.1007\/s13311-021-01145-z_bib109","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1111\/j.1471-4159.1988.tb03035.x","article-title":"Ketone body utilization for lipid synthesis in the murine sciatic nerve: alterations in the dysmyelinating trembler mutant","volume":"50","author":"Clouet","year":"1988","journal-title":"J Neurochem."},{"issue":"1\u20132","key":"10.1007\/s13311-021-01145-z_bib110","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0006-8993(85)90298-7","article-title":"Metabolic alterations of endoneurial lipids in developing trembler nerve","volume":"325","author":"Yao","year":"1985","journal-title":"Brain Res."},{"issue":"2","key":"10.1007\/s13311-021-01145-z_bib111","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0165-3806(86)90207-5","article-title":"A quantitative developmental study of the peripheral nerve lipid composition during myelinogenesis in normal and trembler mice","volume":"390","author":"Heape","year":"1986","journal-title":"Brain Res."},{"key":"10.1007\/s13311-021-01145-z_bib112","doi-asserted-by":"crossref","unstructured":"Zhou Y, Bazick H, Miles JR, Fethiere AI, Salihi MOA, Fazio S, et al. A neutral lipid-enriched diet improves myelination and alleviates peripheral nerve pathology in neuropathic mice. Exp Neurol. 2019;321:113031.","DOI":"10.1016\/j.expneurol.2019.113031"},{"issue":"27","key":"10.1007\/s13311-021-01145-z_bib113","doi-asserted-by":"crossref","first-page":"5404","DOI":"10.1523\/JNEUROSCI.2942-18.2019","article-title":"PMP22 Regulates Cholesterol Trafficking and ABCA1-Mediated Cholesterol Efflux","volume":"39","author":"Zhou","year":"2019","journal-title":"J Neurosci."},{"issue":"6366","key":"10.1007\/s13311-021-01145-z_bib114","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/356241a0","article-title":"Trembler mouse carries a point mutation in a myelin gene","volume":"356","author":"Suter","year":"1992","journal-title":"Nature."},{"key":"10.1007\/s13311-021-01145-z_bib115","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/978-1-4684-8047-4_21","article-title":"Schwann cell proliferation during postnatal development, Wallerian degeneration and axon regeneration in trembler dysmyelinating mutant","volume":"296","author":"Koenig","year":"1991","journal-title":"Adv Exp Med Biol."},{"issue":"10","key":"10.1007\/s13311-021-01145-z_bib116","doi-asserted-by":"crossref","first-page":"4382","DOI":"10.1073\/pnas.89.10.4382","article-title":"A leucine-to-proline mutation in the putative first transmembrane domain of the 22-kDa peripheral myelin protein in the trembler-J mouse","volume":"89","author":"Suter","year":"1992","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"12","key":"10.1007\/s13311-021-01145-z_bib117","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1093\/hmg\/9.12.1865","article-title":"Identification of two new Pmp22 mouse mutants using large-scale mutagenesis and a novel rapid mapping strategy","volume":"9","author":"Isaacs","year":"2000","journal-title":"Hum Mol Genet."},{"issue":"1","key":"10.1007\/s13311-021-01145-z_bib118","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1006\/mcne.2002.1158","article-title":"Identification of a new Pmp22 mouse mutant and trafficking analysis of a Pmp22 allelic series suggesting that protein aggregates may be protective in Pmp22-associated peripheral neuropathy","volume":"21","author":"Isaacs","year":"2002","journal-title":"Mol Cell Neurosci."},{"issue":"5","key":"10.1007\/s13311-021-01145-z_bib119","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1093\/hmg\/5.5.563","article-title":"Construction of a mouse model of Charcot-Marie-Tooth disease type 1A by pronuclear injection of human YAC DNA","volume":"5","author":"Huxley","year":"1996","journal-title":"Hum Mol Genet."},{"key":"10.1007\/s13311-021-01145-z_bib120","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jns.2019.01.030","article-title":"Rodent models with expression of PMP22: Relevance to dysmyelinating CMT and HNPP","volume":"398","author":"Jouaud","year":"2019","journal-title":"J Neurol Sci."},{"issue":"5","key":"10.1007\/s13311-021-01145-z_bib121","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1097\/NEN.0b013e318217eba0","article-title":"Myelin and axon pathology in a long-term study of PMP22-overexpressing mice","volume":"70","author":"Verhamme","year":"2011","journal-title":"J Neuropathol Exp Neurol."},{"issue":"5","key":"10.1007\/s13311-021-01145-z_bib122","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S0896-6273(00)80128-2","article-title":"A transgenic rat model of Charcot-Marie-Tooth disease","volume":"16","author":"Sereda","year":"1996","journal-title":"Neuron."},{"key":"10.1007\/s13311-021-01145-z_bib123","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1186\/s13023-014-0201-x","article-title":"Polytherapy with a combination of three repurposed drugs (PXT3003) down-regulates Pmp22 over-expression and improves myelination, axonal and functional parameters in models of CMT1A neuropathy","volume":"9","author":"Chumakov","year":"2014","journal-title":"Orphanet J Rare Dis."},{"issue":"1","key":"10.1007\/s13311-021-01145-z_bib124","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1038\/s41467-021-22593-3","article-title":"AAV2\/9-mediated silencing of PMP22 prevents the development of pathological features in a rat model of Charcot-Marie-Tooth disease 1 A","volume":"12","author":"Gautier","year":"2021","journal-title":"Nat Commun."},{"issue":"7","key":"10.1007\/s13311-021-01145-z_bib125","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1093\/hmg\/ddr595","article-title":"Distal enhancers upstream of the Charcot-Marie-Tooth type 1A disease gene PMP22","volume":"21","author":"Jones","year":"2012","journal-title":"Hum Mol Genet."},{"issue":"14","key":"10.1007\/s13311-021-01145-z_bib126","doi-asserted-by":"crossref","first-page":"6449","DOI":"10.1093\/nar\/gks313","article-title":"Genome-wide analysis of EGR2\/SOX10 binding in myelinating peripheral nerve","volume":"40","author":"Srinivasan","year":"2012","journal-title":"Nucleic Acids Res."},{"issue":"7","key":"10.1007\/s13311-021-01145-z_bib127","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/s41551-019-0381-8","article-title":"Comparison of three congruent patient-specific cell types for the modelling of a human genetic Schwann-cell disorder","volume":"3","author":"Mukherjee-Clavin","year":"2019","journal-title":"Nat Biomed Eng."},{"issue":"3","key":"10.1007\/s13311-021-01145-z_bib128","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.nmd.2006.12.008","article-title":"Ascorbic acid inhibits PMP22 expression by reducing cAMP levels","volume":"17","author":"Kaya","year":"2007","journal-title":"Neuromuscul Disord."},{"issue":"1\u20132","key":"10.1007\/s13311-021-01145-z_bib129","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0378-1119(00)00116-5","article-title":"Molecular dissection of the Schwann cell specific promoter of the PMP22 gene","volume":"248","author":"Saberan-Djoneidi","year":"2000","journal-title":"Gene."},{"key":"10.1007\/s13311-021-01145-z_bib130","doi-asserted-by":"crossref","unstructured":"Gess B, Baets J, De Jonghe P, Reilly MM, Pareyson D, Young P. Ascorbic acid for the treatment of Charcot-Marie-Tooth disease. Cochrane Database Syst Rev. 2015(12):CD011952.","DOI":"10.1002\/14651858.CD011952"},{"issue":"8","key":"10.1007\/s13311-021-01145-z_bib131","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1001\/jamaneurol.2013.3178","article-title":"High-dosage ascorbic acid treatment in Charcot-Marie-Tooth disease type 1A: results of a randomized, double-masked, controlled trial","volume":"70","author":"Lewis","year":"2013","journal-title":"JAMA Neurol."},{"issue":"4","key":"10.1007\/s13311-021-01145-z_bib132","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/S1474-4422(11)70025-4","article-title":"Ascorbic acid in Charcot-Marie-Tooth disease type 1A (CMT-TRIAAL and CMT-TRAUK): a double-blind randomised trial","volume":"10","author":"Pareyson","year":"2011","journal-title":"Lancet Neurol."},{"key":"10.1007\/s13311-021-01145-z_bib133","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/1741-7015-7-70","article-title":"Oral high dose ascorbic acid treatment for one year in young CMT1A patients: a randomised, double-blind, placebo-controlled phase II trial","volume":"7","author":"Verhamme","year":"2009","journal-title":"BMC Med."},{"issue":"2","key":"10.1007\/s13311-021-01145-z_bib134","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1385\/JMN\/31:02:149","article-title":"Progesterone derivatives increase expression of Krox-20 and Sox-10 in rat Schwann cells","volume":"31","author":"Magnaghi","year":"2007","journal-title":"J Mol Neurosci."},{"issue":"4","key":"10.1007\/s13311-021-01145-z_bib135","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1046\/j.1471-4159.1998.71041765.x","article-title":"Progesterone stimulates the activity of the promoters of peripheral myelin protein-22 and protein zero genes in Schwann cells","volume":"71","author":"Desarnaud","year":"1998","journal-title":"J Neurochem."},{"issue":"4","key":"10.1007\/s13311-021-01145-z_bib136","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/(SICI)1097-4547(19990515)56:4<349::AID-JNR3>3.0.CO;2-H","article-title":"Progesterone derivatives are able to influence peripheral myelin protein 22 and P0 gene expression: possible mechanisms of action","volume":"56","author":"Melcangi","year":"1999","journal-title":"J Neurosci Res."},{"key":"10.1007\/s13311-021-01145-z_bib137","doi-asserted-by":"crossref","unstructured":"Meyer zu Horste G, Prukop T, Liebetanz D, Mobius W, Nave KA, Sereda MW. Antiprogesterone therapy uncouples axonal loss from demyelination in a transgenic rat model of CMT1A neuropathy. Ann Neurol. 2007;61(1):61\u201372.","DOI":"10.1002\/ana.21026"},{"issue":"10","key":"10.1007\/s13311-021-01145-z_bib138","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1111\/j.0953-816X.2004.03368.x","article-title":"GABAB receptors in Schwann cells influence proliferation and myelin protein expression","volume":"19","author":"Magnaghi","year":"2004","journal-title":"Eur J Neurosci."},{"issue":"10","key":"10.1007\/s13311-021-01145-z_bib139","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1002\/jnr.24679","article-title":"Synergistic PXT3003 therapy uncouples neuromuscular function from dysmyelination in male Charcot-Marie-Tooth disease type 1A (CMT1A) rats","volume":"98","author":"Prukop","year":"2020","journal-title":"J Neurosci Res."},{"key":"10.1007\/s13311-021-01145-z_bib140","doi-asserted-by":"crossref","unstructured":"Prukop T, Stenzel J, Wernick S, Kungl T, Mroczek M, Adam J, et al. Early short-term PXT3003 combinational therapy delays disease onset in a transgenic rat model of Charcot-Marie-Tooth disease 1A (CMT1A). PLoS One. 2019;14(1):e0209752.","DOI":"10.1371\/journal.pone.0209752"},{"key":"10.1007\/s13311-021-01145-z_bib141","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1186\/s13023-014-0199-0","article-title":"An exploratory randomised double-blind and placebo-controlled phase 2 study of a combination of baclofen, naltrexone and sorbitol (PXT3003) in patients with Charcot-Marie-Tooth disease type 1A","volume":"9","author":"Attarian","year":"2014","journal-title":"Orphanet J Rare Dis."},{"key":"10.1007\/s13311-021-01145-z_bib142","doi-asserted-by":"crossref","unstructured":"Vita G, Vita GL, Stancanelli C, Gentile L, Russo M, Mazzeo A. Genetic neuromuscular disorders: living the era of a therapeutic revolution. Part 1: peripheral neuropathies. Neurol Sci. 2019;40(4):661\u20139.","DOI":"10.1007\/s10072-019-03778-7"},{"issue":"23","key":"10.1007\/s13311-021-01145-z_bib143","doi-asserted-by":"crossref","first-page":"4698","DOI":"10.1093\/hmg\/ddt318","article-title":"Curcumin facilitates a transitory cellular stress response in Trembler-J mice","volume":"22","author":"Okamoto","year":"2013","journal-title":"Hum Mol Genet."},{"issue":"5","key":"10.1007\/s13311-021-01145-z_bib144","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1086\/497541","article-title":"Curcumin treatment abrogates endoplasmic reticulum retention and aggregation-induced apoptosis associated with neuropathy-causing myelin protein zero-truncating mutants","volume":"77","author":"Khajavi","year":"2005","journal-title":"Am J Hum Genet."},{"issue":"Pt 12","key":"10.1007\/s13311-021-01145-z_bib145","doi-asserted-by":"crossref","first-page":"3551","DOI":"10.1093\/brain\/aws299","article-title":"Curcumin derivatives promote Schwann cell differentiation and improve neuropathy in R98C CMT1B mice","volume":"135","author":"Patzk\u00f3","year":"2012","journal-title":"Brain."},{"key":"10.1007\/s13311-021-01145-z_bib146","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.freeradbiomed.2020.09.019","article-title":"Curcumin-cyclodextrin\/cellulose nanocrystals improve the phenotype of Charcot-Marie-Tooth-1A transgenic rats through the reduction of oxidative stress","volume":"161","author":"Caillaud","year":"2020","journal-title":"Free Radic Biol Med."},{"issue":"6","key":"10.1007\/s13311-021-01145-z_bib147","doi-asserted-by":"crossref","first-page":"2890","DOI":"10.1021\/acschemneuro.9b00105","article-title":"HSP90 Inhibitor, NVP-AUY922, Improves Myelination in Vitro and Supports the Maintenance of Myelinated Axons in Neuropathic Mice","volume":"10","author":"Chittoor-Vinod","year":"2019","journal-title":"ACS Chem Neurosci."},{"issue":"39","key":"10.1007\/s13311-021-01145-z_bib148","doi-asserted-by":"crossref","first-page":"33097","DOI":"10.1074\/jbc.R500010200","article-title":"Heat shock response modulators as therapeutic tools for diseases of protein conformation","volume":"280","author":"Westerheide","year":"2005","journal-title":"J Biol Chem."},{"issue":"22","key":"10.1007\/s13311-021-01145-z_bib149","doi-asserted-by":"crossref","first-page":"5096","DOI":"10.1111\/bph.15231","article-title":"A novel histone deacetylase 6 inhibitor improves myelination of Schwann cells in a model of Charcot-Marie-Tooth disease type 1A","volume":"177","author":"Ha","year":"2020","journal-title":"Br J Pharmacol."},{"issue":"8","key":"10.1007\/s13311-021-01145-z_bib150","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1038\/nm.2396","article-title":"HDAC6 inhibitors reverse axonal loss in a mouse model of mutant HSPB1-induced Charcot-Marie-Tooth disease","volume":"17","author":"d'Ydewalle","year":"2011","journal-title":"Nat Med."},{"issue":"1","key":"10.1007\/s13311-021-01145-z_bib151","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1716153","article-title":"Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis","volume":"379","author":"Adams","year":"2018","journal-title":"N Engl J Med."},{"key":"10.1007\/s13311-021-01145-z_bib152","doi-asserted-by":"crossref","unstructured":"Sahenk Z, Galloway G, Clark KR, Malik V, Rodino-Klapac LR, Kaspar BK, et al. AAV1.NT-3 gene therapy for charcot-marie-tooth neuropathy. Mol Ther. 2014;22(3):511\u201321.","DOI":"10.1038\/mt.2013.250"},{"key":"10.1007\/s13311-021-01145-z_bib153","doi-asserted-by":"crossref","unstructured":"Sargiannidou I, Kagiava A, Kleopa KA. Gene therapy approaches targeting Schwann cells for demyelinating neuropathies. Brain Res. 2020;1728:146572.","DOI":"10.1016\/j.brainres.2019.146572"},{"issue":"6","key":"10.1007\/s13311-021-01145-z_bib154","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1111\/j.1742-4658.2009.06908.x","article-title":"Ribonuclease H: the enzymes in eukaryotes","volume":"276","author":"Cerritelli","year":"2009","journal-title":"FEBS J."},{"issue":"1","key":"10.1007\/s13311-021-01145-z_bib155","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1172\/JCI98617","article-title":"Antisense oligonucleotides offer hope to patients with Charcot-Marie-Tooth disease type 1A","volume":"128","author":"Shy","year":"2018","journal-title":"J Clin Invest."},{"issue":"1","key":"10.1007\/s13311-021-01145-z_bib156","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1177\/0192623314551840","article-title":"Antisense oligonucleotide therapies: the promise and the challenges from a toxicologic pathologist's perspective","volume":"43","author":"Frazier","year":"2015","journal-title":"Toxicol Pathol."},{"issue":"8","key":"10.1007\/s13311-021-01145-z_bib157","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1002\/acn3.51133","article-title":"Fatigue in patients with hereditary neuropathy with liability to pressure palsies","volume":"7","author":"Fritz","year":"2020","journal-title":"Ann Clin Transl Neurol."},{"key":"10.1007\/s13311-021-01145-z_bib158","doi-asserted-by":"crossref","unstructured":"Bjelica B, Peric S, Bozovic I, Jankovic M, Brankovic M, Palibrk A, et al. Quality of life in hereditary neuropathy with liability to pressure palsies is as impaired as in Charcot-Marie-Tooth disease type 1A. Acta Neurol Belg. 2020.","DOI":"10.1007\/s13760-020-01355-w"},{"key":"10.1007\/s13311-021-01145-z_bib159","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.jconrel.2020.02.032","article-title":"Small interfering RNA from the lab discovery to patients' recovery","volume":"321","author":"Caillaud","year":"2020","journal-title":"J Control Release."},{"key":"10.1007\/s13311-021-01145-z_bib160","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.nbd.2017.01.006","article-title":"Pmp22 mutant allele-specific siRNA alleviates demyelinating neuropathic phenotype in vivo","volume":"100","author":"Lee","year":"2017","journal-title":"Neurobiol Dis."},{"issue":"1","key":"10.1007\/s13311-021-01145-z_bib161","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/s42003-021-01839-2","article-title":"Squalenoyl siRNA PMP22 nanoparticles are effective in treating mouse models of Charcot-Marie-Tooth disease type 1 A","volume":"4","author":"Boutary","year":"2021","journal-title":"Commun Biol."},{"issue":"1","key":"10.1007\/s13311-021-01145-z_bib162","first-page":"130","article-title":"Targeted PMP22 TATA-box editing by CRISPR\/Cas9 reduces demyelinating neuropathy of Charcot-Marie-Tooth disease type 1A in mice","volume":"48","author":"Lee","year":"2020","journal-title":"Nucleic Acids Res."},{"issue":"7","key":"10.1007\/s13311-021-01145-z_bib163","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1038\/s41593-021-00827-3","article-title":"Gain of toxic function by long-term AAV9-mediated SMN overexpression in the sensorimotor circuit","volume":"24","author":"Van Alstyne","year":"2021","journal-title":"Nat Neurosci."},{"issue":"1","key":"10.1007\/s13311-021-01145-z_bib164","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1159\/000472166","article-title":"Estimation of the mutation frequencies in Charcot-Marie-Tooth disease type 1 and hereditary neuropathy with liability to pressure palsies: a European collaborative study","volume":"4","author":"Nelis","year":"1996","journal-title":"Eur J Hum Genet."},{"issue":"Pt 2","key":"10.1007\/s13311-021-01145-z_bib165","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1093\/brain\/awh048","article-title":"Phenotypic clustering in MPZ mutations","volume":"127","author":"Shy","year":"2004","journal-title":"Brain."},{"issue":"2","key":"10.1007\/s13311-021-01145-z_bib166","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/BF00687025","article-title":"Ultrastructural study of a nerve biopsy from a case of early infantile chronic neuropathy","volume":"13","author":"Lyon","year":"1969","journal-title":"Acta Neuropathol."},{"issue":"4","key":"10.1007\/s13311-021-01145-z_bib167","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1111\/j.1469-8749.1975.tb03502.x","article-title":"Infantile polyneuropathy with defective myelination: an autopsy study","volume":"17","author":"Karch","year":"1975","journal-title":"Dev Med Child Neurol."},{"key":"10.1007\/s13311-021-01145-z_bib168","doi-asserted-by":"crossref","unstructured":"Kennedy WR, Sung JH, Berry JF. A case of congenital hypomyelination neuropathy. Clinical, morphological, and chemical studies. Arch Neurol. 1977;34(6):337\u201345.","DOI":"10.1001\/archneur.1977.00500180031007"},{"issue":"4","key":"10.1007\/s13311-021-01145-z_bib169","first-page":"183","article-title":"Progressive familial hypertrophic polyneuritis (Dejerine-Sottas Syndrome, 1893)","volume":"49","author":"Cox","year":"1956","journal-title":"Proc R Soc Med."},{"issue":"Pt 11","key":"10.1007\/s13311-021-01145-z_bib170","doi-asserted-by":"crossref","first-page":"3180","DOI":"10.1093\/brain\/awv241","article-title":"Genotype-phenotype characteristics and baseline natural history of heritable neuropathies caused by mutations in the MPZ gene","volume":"138","author":"Sanmaneechai","year":"2015","journal-title":"Brain."},{"issue":"Pt 1","key":"10.1007\/s13311-021-01145-z_bib171","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1093\/brain\/awg012","article-title":"Demyelinating and axonal features of Charcot-Marie-Tooth disease with mutations of myelin-related proteins (PMP22, MPZ and Cx32): a clinicopathological study of 205 Japanese patients","volume":"126","author":"Hattori","year":"2003","journal-title":"Brain."},{"key":"10.1007\/s13311-021-01145-z_bib172","doi-asserted-by":"crossref","unstructured":"Murphy SM, Laur\u00e1 M, Blake J, Polke J, Bremner F, Reilly MM. Conduction block and tonic pupils in Charcot-Marie-Tooth disease caused by a myelin protein zero p.Ile112Thr mutation. Neuromuscul Disord. 2011;21(3):223\u20136.","DOI":"10.1016\/j.nmd.2010.12.010"},{"issue":"5","key":"10.1007\/s13311-021-01145-z_bib173","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1002\/1531-8249(199905)45:5<676::AID-ANA21>3.0.CO;2-K","article-title":"Congenital hypomyelination due to myelin protein zero Q215X mutation","volume":"45","author":"Mandich","year":"1999","journal-title":"Ann Neurol."},{"issue":"3","key":"10.1007\/s13311-021-01145-z_bib174","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S0896-6273(00)80177-4","article-title":"Clinical phenotypes of different MPZ (P0) mutations may include Charcot-Marie-Tooth type 1B, Dejerine-Sottas, and congenital hypomyelination","volume":"17","author":"Warner","year":"1996","journal-title":"Neuron."},{"issue":"4","key":"10.1007\/s13311-021-01145-z_bib175","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1002\/(SICI)1098-1004(200004)15:4<340::AID-HUMU6>3.0.CO;2-Y","article-title":"Screening for mutations in the peripheral myelin genes PMP22, MPZ and Cx32 (GJB1) in Russian Charcot-Marie-Tooth neuropathy patients","volume":"15","author":"Mersiyanova","year":"2000","journal-title":"Hum Mutat."},{"issue":"6","key":"10.1007\/s13311-021-01145-z_bib176","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1002\/mus.20034","article-title":"Clinical and genetic description of a family with Charcot-Marie-Tooth disease type 1B from a transmembrane MPZ mutation","volume":"29","author":"Eggers","year":"2004","journal-title":"Muscle Nerve."},{"issue":"Pt 2","key":"10.1007\/s13311-021-01145-z_bib177","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1093\/brain\/122.2.281","article-title":"The Thr124Met mutation in the peripheral myelin protein zero (MPZ) gene is associated with a clinically distinct Charcot-Marie-Tooth phenotype","volume":"122","author":"De Jonghe","year":"1999","journal-title":"Brain."},{"issue":"2","key":"10.1007\/s13311-021-01145-z_bib178","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1002\/cne.21051","article-title":"Major myelin protein gene (P0) mutation causes a novel form of axonal degeneration","volume":"498","author":"Li","year":"2006","journal-title":"J Comp Neurol."},{"issue":"1","key":"10.1007\/s13311-021-01145-z_bib179","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/(SICI)1098-1004(1999)13:1<11::AID-HUMU2>3.0.CO;2-A","article-title":"Mutations in the peripheral myelin genes and associated genes in inherited peripheral neuropathies","volume":"13","author":"Nelis","year":"1999","journal-title":"Hum Mutat."},{"issue":"4","key":"10.1007\/s13311-021-01145-z_bib180","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1002\/ana.410410409","article-title":"Clinical and pathological phenotype of the original family with Charcot-Marie-Tooth type 1B: a 20-year study","volume":"41","author":"Bird","year":"1997","journal-title":"Ann Neurol."},{"issue":"12","key":"10.1007\/s13311-021-01145-z_bib181","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1001\/archneur.63.12.1787","article-title":"Effect of an R69C mutation in the myelin protein zero gene on myelination and ion channel subtypes","volume":"63","author":"Bai","year":"2006","journal-title":"Arch Neurol."},{"issue":"4","key":"10.1007\/s13311-021-01145-z_bib182","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1111\/j.1529-8027.2012.00443.x","article-title":"Myelin protein zero Arg36Gly mutation with very late onset and rapidly progressive painful neuropathy","volume":"17","author":"Dacci","year":"2012","journal-title":"J Peripher Nerv Syst."},{"issue":"3","key":"10.1007\/s13311-021-01145-z_bib183","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/0092-8674(85)90198-9","article-title":"Isolation and sequence of a cDNA encoding the major structural protein of peripheral myelin","volume":"40","author":"Lemke","year":"1985","journal-title":"Cell."},{"key":"10.1007\/s13311-021-01145-z_bib184","first-page":"162","article-title":"Endoplasmic Reticulum Protein Quality Control Failure in Myelin Disorders","volume":"9","author":"Volpi","year":"2016","journal-title":"Front Mol Neurosci."},{"issue":"1","key":"10.1007\/s13311-021-01145-z_bib185","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/ng0993-31","article-title":"Charcot-Marie-Tooth neuropathy type 1B is associated with mutations of the myelin P0 gene","volume":"5","author":"Hayasaka","year":"1993","journal-title":"Nat Genet."},{"issue":"1","key":"10.1007\/s13311-021-01145-z_bib186","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1083\/jcb.90.1.1","article-title":"Immunocytochemical localization of P0 protein in Golgi complex membranes and myelin of developing rat Schwann cells","volume":"90","author":"Trapp","year":"1981","journal-title":"J Cell Biol."},{"issue":"3 Pt 1","key":"10.1007\/s13311-021-01145-z_bib187","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1523\/JNEUROSCI.15-03-01797.1995","article-title":"Polarization of myelinating Schwann cell surface membranes: role of microtubules and the trans-Golgi network","volume":"15","author":"Trapp","year":"1995","journal-title":"J Neurosci."},{"issue":"4","key":"10.1007\/s13311-021-01145-z_bib188","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/jnr.490320406","article-title":"Myelin protein expression in dissociated superior cervical ganglia and dorsal root ganglia cultures","volume":"32","author":"Brunden","year":"1992","journal-title":"J Neurosci Res."},{"issue":"3","key":"10.1007\/s13311-021-01145-z_bib189","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/0896-6273(90)90057-M","article-title":"Protein zero of peripheral nerve myelin: biosynthesis, membrane insertion, and evidence for homotypic interaction","volume":"4","author":"D'Urso","year":"1990","journal-title":"Neuron."},{"issue":"11","key":"10.1007\/s13311-021-01145-z_bib190","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1023\/A:1021619631869","article-title":"Myelin P0: new knowledge and new roles","volume":"27","author":"Eichberg","year":"2002","journal-title":"Neurochem Res."},{"key":"10.1007\/s13311-021-01145-z_bib191","doi-asserted-by":"crossref","unstructured":"Br\u00fcgger V, Engler S, Pereira JA, Ruff S, Horn M, Welzl H, et al. HDAC1\/2-Dependent P0 Expression Maintains Paranodal and Nodal Integrity Independently of Myelin Stability through Interactions with Neurofascins. PLoS Biol. 2015;13(9):e1002258.","DOI":"10.1371\/journal.pbio.1002258"},{"issue":"6269","key":"10.1007\/s13311-021-01145-z_bib192","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1038\/344871a0","article-title":"Role of myelin P0 protein as a homophilic adhesion molecule","volume":"344","author":"Filbin","year":"1990","journal-title":"Nature."},{"issue":"4","key":"10.1007\/s13311-021-01145-z_bib193","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1111\/j.1471-4159.1973.tb00089.x","article-title":"Protein composition of myelin of the peripheral nervous system","volume":"20","author":"Greenfield","year":"1973","journal-title":"J Neurochem."},{"issue":"3","key":"10.1007\/s13311-021-01145-z_bib194","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0896-6273(00)80176-2","article-title":"Crystal structure of the extracellular domain from P0, the major structural protein of peripheral nerve myelin","volume":"17","author":"Shapiro","year":"1996","journal-title":"Neuron."},{"issue":"5","key":"10.1007\/s13311-021-01145-z_bib195","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1083\/jcb.148.5.1021","article-title":"P(0) glycoprotein overexpression causes congenital hypomyelination of peripheral nerves","volume":"148","author":"Wrabetz","year":"2000","journal-title":"J Cell Biol."},{"issue":"4","key":"10.1007\/s13311-021-01145-z_bib196","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/0092-8674(92)90591-Y","article-title":"Mouse P0 gene disruption leads to hypomyelination, abnormal expression of recognition molecules, and degeneration of myelin and axons","volume":"71","author":"Giese","year":"1992","journal-title":"Cell."},{"issue":"13","key":"10.1007\/s13311-021-01145-z_bib197","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1093\/hmg\/ddn083","article-title":"Different cellular and molecular mechanisms for early and late-onset myelin protein zero mutations","volume":"17","author":"Grandis","year":"2008","journal-title":"Hum Mol Genet."},{"issue":"3","key":"10.1007\/s13311-021-01145-z_bib198","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1083\/jcb.200107114","article-title":"Mutations in the cytoplasmic domain of P0 reveal a role for PKC-mediated phosphorylation in adhesion and myelination","volume":"155","author":"Xu","year":"2001","journal-title":"J Cell Biol."},{"issue":"8","key":"10.1007\/s13311-021-01145-z_bib199","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1523\/JNEUROSCI.3819-05.2006","article-title":"Different intracellular pathomechanisms produce diverse Myelin Protein Zero neuropathies in transgenic mice","volume":"26","author":"Wrabetz","year":"2006","journal-title":"J Neurosci."},{"issue":"1","key":"10.1007\/s13311-021-01145-z_bib200","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1093\/hmg\/ddy336","article-title":"A nonsense mutation in myelin protein zero causes congenital hypomyelination neuropathy through altered P0 membrane targeting and gain of abnormal function","volume":"28","author":"Fratta","year":"2019","journal-title":"Hum Mol Genet."},{"issue":"1","key":"10.1007\/s13311-021-01145-z_bib201","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/j.1749-6632.1999.tb08579.x","article-title":"Characterization of the Effect on Adhesion of Different Mutations in Myelin P(0) Protein","volume":"883","author":"Filbin","year":"1999","journal-title":"Ann N Y Acad Sci."},{"issue":"4","key":"10.1007\/s13311-021-01145-z_bib202","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1002\/(SICI)1097-4547(19961115)46:4<502::AID-JNR12>3.0.CO;2-#","article-title":"Inherited demyelinating peripheral neuropathies: relating myelin packing abnormalities to P0 molecular defects","volume":"46","author":"Kirschner","year":"1996","journal-title":"J Neurosci Res."},{"issue":"3","key":"10.1007\/s13311-021-01145-z_bib203","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1002\/ana.22695","article-title":"Gain of glycosylation: a new pathomechanism of myelin protein zero mutations","volume":"71","author":"Prada","year":"2012","journal-title":"Ann Neurol."},{"issue":"2","key":"10.1007\/s13311-021-01145-z_bib204","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/(SICI)1098-1004(1996)8:2<185::AID-HUMU13>3.0.CO;2-Z","article-title":"Charcot-Marie-Tooth type 1B neuropathy: a mutation at the single glycosylation site in the major peripheral myelin glycoprotein Po","volume":"8","author":"Blanquet-Grossard","year":"1996","journal-title":"Hum Mutat."},{"issue":"4","key":"10.1007\/s13311-021-01145-z_bib205","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1083\/jcb.126.4.1089","article-title":"The cytoplasmic domain of the myelin P0 protein influences the adhesive interactions of its extracellular domain","volume":"126","author":"Wong","year":"1994","journal-title":"J Cell Biol."},{"issue":"4","key":"10.1007\/s13311-021-01145-z_bib206","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1083\/jcb.200608060","article-title":"Myelin protein zero\/P0 phosphorylation and function require an adaptor protein linking it to RACK1 and PKC alpha","volume":"177","author":"Gaboreanu","year":"2007","journal-title":"J Cell Biol."},{"issue":"6","key":"10.1007\/s13311-021-01145-z_bib207","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1002\/1097-4547(20000615)60:6<714::AID-JNR3>3.0.CO;2-1","article-title":"Absence of P0 leads to the dysregulation of myelin gene expression and myelin morphogenesis","volume":"60","author":"Xu","year":"2000","journal-title":"J Neurosci Res."},{"issue":"6","key":"10.1007\/s13311-021-01145-z_bib208","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1006\/mcne.2001.1041","article-title":"Protein zero is necessary for E-cadherin-mediated adherens junction formation in Schwann cells","volume":"18","author":"Menichella","year":"2001","journal-title":"Mol Cell Neurosci."},{"key":"10.1007\/s13311-021-01145-z_bib209","doi-asserted-by":"crossref","unstructured":"Moldovan M, Alvarez S, Pinchenko V, Klein D, Nielsen FC, Wood JN, et al. Na(v)1.8 channelopathy in mutant mice deficient for myelin protein zero is detrimental to motor axons. Brain. 2011;134(Pt 2):585\u2013601.","DOI":"10.1093\/brain\/awq336"},{"issue":"10","key":"10.1007\/s13311-021-01145-z_bib210","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1016\/j.clinph.2020.06.034","article-title":"Myelin protein zero gene dose dependent axonal ion-channel dysfunction in a family with Charcot-Marie-Tooth disease","volume":"131","author":"Moldovan","year":"2020","journal-title":"Clin Neurophysiol."},{"key":"10.1007\/s13311-021-01145-z_bib211","doi-asserted-by":"crossref","unstructured":"Musner N, Sidoli M, Zambroni D, Del Carro U, Ungaro D, D'Antonio M, et al. Perk Ablation Ameliorates Myelination in S63del-Charcot-Marie-Tooth 1B Neuropathy. ASN Neuro. 2016;8(2).","DOI":"10.1177\/1759091416642351"},{"issue":"15","key":"10.1007\/s13311-021-01145-z_bib212","doi-asserted-by":"crossref","first-page":"3241","DOI":"10.1002\/jnr.22066","article-title":"Myelin under stress","volume":"87","author":"D'Antonio","year":"2009","journal-title":"J Neurosci Res."},{"issue":"5","key":"10.1007\/s13311-021-01145-z_bib213","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.conb.2009.08.007","article-title":"CHOP and the endoplasmic reticulum stress response in myelinating glia","volume":"19","author":"Gow","year":"2009","journal-title":"Curr Opin Neurobiol."},{"issue":"2","key":"10.1007\/s13311-021-01145-z_bib214","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.ceb.2011.01.003","article-title":"Protein folding stress in neurodegenerative diseases: a glimpse into the ER","volume":"23","author":"Matus","year":"2011","journal-title":"Curr Opin Cell Biol."},{"issue":"7","key":"10.1007\/s13311-021-01145-z_bib215","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/nrm2199","article-title":"Signal integration in the endoplasmic reticulum unfolded protein response","volume":"8","author":"Ron","year":"2007","journal-title":"Nat Rev Mol Cell Biol."},{"issue":"7","key":"10.1007\/s13311-021-01145-z_bib216","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/ncb3184","article-title":"Proteostasis control by the unfolded protein response","volume":"17","author":"Hetz","year":"2015","journal-title":"Nat Cell Biol."},{"issue":"Pt 7","key":"10.1007\/s13311-021-01145-z_bib217","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1093\/brain\/aws140","article-title":"MpzR98C arrests Schwann cell development in a mouse model of early-onset Charcot-Marie-Tooth disease type 1B","volume":"135","author":"Saporta","year":"2012","journal-title":"Brain."},{"issue":"7","key":"10.1007\/s13311-021-01145-z_bib218","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/35017001","article-title":"A regulatory link between ER-associated protein degradation and the unfolded-protein response","volume":"2","author":"Friedlander","year":"2000","journal-title":"Nat Cell Biol."},{"issue":"3","key":"10.1007\/s13311-021-01145-z_bib219","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0092-8674(00)80835-1","article-title":"Functional and genomic analyses reveal an essential coordination between the unfolded protein response and ER-associated degradation","volume":"101","author":"Travers","year":"2000","journal-title":"Cell."},{"issue":"11","key":"10.1007\/s13311-021-01145-z_bib220","doi-asserted-by":"crossref","first-page":"3787","DOI":"10.1091\/mbc.10.11.3787","article-title":"Mammalian transcription factor ATF6 is synthesized as a transmembrane protein and activated by proteolysis in response to endoplasmic reticulum stress","volume":"10","author":"Haze","year":"1999","journal-title":"Mol Biol Cell."},{"issue":"18","key":"10.1007\/s13311-021-01145-z_bib221","doi-asserted-by":"crossref","first-page":"6755","DOI":"10.1128\/MCB.20.18.6755-6767.2000","article-title":"ATF6 activated by proteolysis binds in the presence of NF-Y (CBF) directly to the cis-acting element responsible for the mammalian unfolded protein response","volume":"20","author":"Yoshida","year":"2000","journal-title":"Mol Cell Biol."},{"issue":"7","key":"10.1007\/s13311-021-01145-z_bib222","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/S0092-8674(01)00611-0","article-title":"XBP1 mRNA is induced by ATF6 and spliced by IRE1 in response to ER stress to produce a highly active transcription factor","volume":"107","author":"Yoshida","year":"2001","journal-title":"Cell."},{"issue":"1","key":"10.1007\/s13311-021-01145-z_bib223","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S1534-5807(02)00203-4","article-title":"ER stress regulation of ATF6 localization by dissociation of BiP\/GRP78 binding and unmasking of Golgi localization signals","volume":"3","author":"Shen","year":"2002","journal-title":"Dev Cell."},{"issue":"2","key":"10.1007\/s13311-021-01145-z_bib224","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.jbiotec.2007.05.028","article-title":"Effects of protein conformational changes on separation performance in electrostatic interaction chromatography: unfolded proteins and PEGylated proteins","volume":"132","author":"Yamamoto","year":"2007","journal-title":"J Biotechnol."},{"key":"10.1007\/s13311-021-01145-z_bib225","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1101\/sqb.2001.66.499","article-title":"Translational regulation in the cellular response to biosynthetic load on the endoplasmic reticulum","volume":"66","author":"Harding","year":"2001","journal-title":"Cold Spring Harb Symp Quant Biol."},{"issue":"5","key":"10.1007\/s13311-021-01145-z_bib226","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1083\/jcb.153.5.1011","article-title":"Feedback inhibition of the unfolded protein response by GADD34-mediated dephosphorylation of eIF2alpha","volume":"153","author":"Novoa","year":"2001","journal-title":"J Cell Biol."},{"issue":"7","key":"10.1007\/s13311-021-01145-z_bib227","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1101\/gad.12.7.982","article-title":"CHOP is implicated in programmed cell death in response to impaired function of the endoplasmic reticulum","volume":"12","author":"Zinszner","year":"1998","journal-title":"Genes Dev."},{"issue":"5","key":"10.1007\/s13311-021-01145-z_bib228","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/S1097-2765(00)00108-8","article-title":"Regulated translation initiation controls stress-induced gene expression in mammalian cells","volume":"6","author":"Harding","year":"2000","journal-title":"Mol Cell."},{"issue":"3","key":"10.1007\/s13311-021-01145-z_bib229","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.neuron.2007.12.021","article-title":"Ablation of the UPR-mediator CHOP restores motor function and reduces demyelination in Charcot-Marie-Tooth 1B mice","volume":"57","author":"Pennuto","year":"2008","journal-title":"Neuron."},{"issue":"4","key":"10.1007\/s13311-021-01145-z_bib230","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1084\/jem.20122005","article-title":"Resetting translational homeostasis restores myelination in Charcot-Marie-Tooth disease type 1B mice","volume":"210","author":"D'Antonio","year":"2013","journal-title":"J Exp Med."},{"issue":"44","key":"10.1007\/s13311-021-01145-z_bib231","doi-asserted-by":"crossref","first-page":"11350","DOI":"10.1523\/JNEUROSCI.1637-16.2016","article-title":"Ablation of Perk in Schwann Cells Improves Myelination in the S63del Charcot-Marie-Tooth 1B Mouse","volume":"36","author":"Sidoli","year":"2016","journal-title":"J Neurosci."},{"issue":"4","key":"10.1007\/s13311-021-01145-z_bib232","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1002\/acn3.543","article-title":"Myelin protein zero mutations and the unfolded protein response in Charcot Marie Tooth disease type 1B","volume":"5","author":"Bai","year":"2018","journal-title":"Ann Clin Transl Neurol."},{"issue":"4","key":"10.1007\/s13311-021-01145-z_bib233","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/nn.2273","article-title":"Endoplasmic reticulum stress in disorders of myelinating cells","volume":"12","author":"Lin","year":"2009","journal-title":"Nat Neurosci."},{"issue":"Pt B","key":"10.1007\/s13311-021-01145-z_bib234","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.brainres.2016.03.046","article-title":"Endoplasmic reticulum stress and the unfolded protein response in disorders of myelinating glia","volume":"1648","author":"Clayton","year":"2016","journal-title":"Brain Res."},{"issue":"11","key":"10.1007\/s13311-021-01145-z_bib235","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1093\/hmg\/ddr081","article-title":"P0S63del impedes the arrival of wild-type P0 glycoprotein to myelin in CMT1B mice","volume":"20","author":"Fratta","year":"2011","journal-title":"Hum Mol Genet."},{"issue":"2","key":"10.1007\/s13311-021-01145-z_bib236","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1529-8027.2012.00398.x","article-title":"Phenotypic presentation of the Ser63Del MPZ mutation","volume":"17","author":"Miller","year":"2012","journal-title":"J Peripher Nerv Syst."},{"issue":"3","key":"10.1007\/s13311-021-01145-z_bib237","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1212\/WNL.47.3.761","article-title":"Two divergent types of nerve pathology in patients with different P0 mutations in Charcot-Marie-Tooth disease","volume":"47","author":"Gabre\u00ebls-Festen","year":"1996","journal-title":"Neurology."},{"issue":"1","key":"10.1007\/s13311-021-01145-z_bib238","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/ng0993-35","article-title":"Deletion of the serine 34 codon from the major peripheral myelin protein P0 gene in Charcot-Marie-Tooth disease type 1B","volume":"5","author":"Kulkens","year":"1993","journal-title":"Nat Genet."},{"issue":"14","key":"10.1007\/s13311-021-01145-z_bib239","doi-asserted-by":"crossref","first-page":"6058","DOI":"10.1523\/JNEUROSCI.19-14-06058.1999","article-title":"Loss of distal axons and sensory Merkel cells and features indicative of muscle denervation in hindlimbs of P0-deficient mice","volume":"19","author":"Frei","year":"1999","journal-title":"J Neurosci."},{"key":"10.1007\/s13311-021-01145-z_bib240","doi-asserted-by":"crossref","unstructured":"Bai Y, Patzko A, Shy ME. Unfolded protein response, treatment and CMT1B. Rare Dis. 2013;1:e24049.","DOI":"10.4161\/rdis.24049"},{"issue":"5711","key":"10.1007\/s13311-021-01145-z_bib241","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1126\/science.1101902","article-title":"A selective inhibitor of eIF2alpha dephosphorylation protects cells from ER stress","volume":"307","author":"Boyce","year":"2005","journal-title":"Science."},{"issue":"6231","key":"10.1007\/s13311-021-01145-z_bib242","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1126\/science.aaa4484","article-title":"Preventing proteostasis diseases by selective inhibition of a phosphatase regulatory subunit","volume":"348","author":"Das","year":"2015","journal-title":"Science."},{"key":"10.1007\/s13311-021-01145-z_bib243","doi-asserted-by":"crossref","unstructured":"Volpi VG, Ferri C, Fregno I, Del Carro U, Bianchi F, Scapin C, et al. Schwann cells ER-associated degradation contributes to myelin maintenance in adult nerves and limits demyelination in CMT1B mice. PLoS Genet. 2019;15(4):e1008069.","DOI":"10.1371\/journal.pgen.1008069"},{"issue":"6","key":"10.1007\/s13311-021-01145-z_bib244","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1093\/hmg\/ddy411","article-title":"Enhanced axonal neuregulin-1 type-III signaling ameliorates neurophysiology and hypomyelination in a Charcot-Marie-Tooth type 1B mouse model","volume":"28","author":"Scapin","year":"2019","journal-title":"Hum Mol Genet."},{"key":"10.1007\/s13311-021-01145-z_bib245","doi-asserted-by":"crossref","unstructured":"Rosberg MR, Alvarez S, Krarup C, Moldovan M. An oral NaV1.8 blocker improves motor function in mice completely deficient of myelin protein P0. Neurosci Lett. 2016;632:33\u20138.","DOI":"10.1016\/j.neulet.2016.08.019"},{"issue":"Pt 11","key":"10.1007\/s13311-021-01145-z_bib246","doi-asserted-by":"crossref","first-page":"3193","DOI":"10.1093\/brain\/awv240","article-title":"Targeting the colony stimulating factor 1 receptor alleviates two forms of Charcot-Marie-Tooth disease in mice","volume":"138","author":"Klein","year":"2015","journal-title":"Brain."},{"issue":"2","key":"10.1007\/s13311-021-01145-z_bib247","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1093\/hmg\/3.2.355","article-title":"Point mutations of the connexin32 (GJB1) gene in X-linked dominant Charcot-Marie-Tooth neuropathy","volume":"3","author":"Ionasescu","year":"1994","journal-title":"Hum Mol Genet."},{"issue":"6","key":"10.1007\/s13311-021-01145-z_bib248","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/mgg3.106","article-title":"The allelic spectrum of Charcot-Marie-Tooth disease in over 17,000 individuals with neuropathy","volume":"2","author":"DiVincenzo","year":"2014","journal-title":"Mol Genet Genomic Med."},{"issue":"11","key":"10.1007\/s13311-021-01145-z_bib249","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1212\/01.wnl.0000256709.08271.4d","article-title":"CMT1X phenotypes represent loss of GJB1 gene function","volume":"68","author":"Shy","year":"2007","journal-title":"Neurology."},{"issue":"15","key":"10.1007\/s13311-021-01145-z_bib250","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1212\/WNL.0000000000003819","article-title":"Mutations in noncoding regions of GJB1 are a major cause of X-linked CMT","volume":"88","author":"Tomaselli","year":"2017","journal-title":"Neurology."},{"issue":"8","key":"10.1007\/s13311-021-01145-z_bib251","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.nmd.2017.05.001","article-title":"Deletion of P2 promoter of GJB1 gene a cause of Charcot-Marie-Tooth disease","volume":"27","author":"Kulshrestha","year":"2017","journal-title":"Neuromuscul Disord."},{"key":"10.1007\/s13311-021-01145-z_bib252","doi-asserted-by":"crossref","first-page":"413","DOI":"10.3389\/fneur.2019.00413","article-title":"A Novel Variant in Non-coding Region of GJB1 Is Associated With X-Linked Charcot-Marie-Tooth Disease Type 1 and Transient CNS Symptoms","volume":"10","author":"Luo","year":"2019","journal-title":"Front Neurol."},{"key":"10.1007\/s13311-021-01145-z_bib253","doi-asserted-by":"crossref","unstructured":"Boso F, Taioli F, Cabrini I, Cavallaro T, Fabrizi GM. Aberrant Splicing in GJB1 and the Relevance of 5' UTR in CMTX1 Pathogenesis. Brain Sci. 2020;11(1).","DOI":"10.3390\/brainsci11010024"},{"issue":"4","key":"10.1007\/s13311-021-01145-z_bib254","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s10048-010-0247-4","article-title":"GJB1\/Connexin 32 whole gene deletions in patients with X-linked Charcot-Marie-Tooth disease","volume":"11","author":"Gonzaga-Jauregui","year":"2010","journal-title":"Neurogenetics."},{"issue":"2","key":"10.1007\/s13311-021-01145-z_bib255","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/ene.12434","article-title":"Contribution of copy number variations in CMT1X: a retrospective study","volume":"22","author":"Capponi","year":"2015","journal-title":"Eur J Neurol."},{"issue":"9","key":"10.1007\/s13311-021-01145-z_bib256","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1212\/WNL.0000000000004296","article-title":"Cross-sectional analysis of a large cohort with X-linked Charcot-Marie-Tooth disease (CMTX1)","volume":"89","author":"Panosyan","year":"2017","journal-title":"Neurology."},{"issue":"2","key":"10.1007\/s13311-021-01145-z_bib257","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/j.1529-8027.2011.00332.x","article-title":"Phenotype expression in women with CMT1X","volume":"16","author":"Siskind","year":"2011","journal-title":"J Peripher Nerv Syst."},{"issue":"1","key":"10.1007\/s13311-021-01145-z_bib258","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/jns.12362","article-title":"Sporadic hereditary neuropathies misdiagnosed as chronic inflammatory demyelinating polyradiculoneuropathy: Pitfalls and red flags","volume":"25","author":"Campagnolo","year":"2020","journal-title":"J Peripher Nerv Syst."},{"issue":"6","key":"10.1007\/s13311-021-01145-z_bib259","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1136\/jnnp.2008.150557","article-title":"GJB1 gene mutations in suspected inflammatory demyelinating neuropathies not responding to treatment","volume":"80","author":"Michell","year":"2009","journal-title":"J Neurol Neurosurg Psychiatry."},{"issue":"1","key":"10.1007\/s13311-021-01145-z_bib260","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/acn3.51271","article-title":"Systematic review of CMTX1 patients with episodic neurological dysfunction","volume":"8","author":"Tian","year":"2021","journal-title":"Ann Clin Transl Neurol."},{"issue":"1","key":"10.1007\/s13311-021-01145-z_bib261","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/(SICI)1098-1136(199809)24:1<8::AID-GLIA2>3.0.CO;2-3","article-title":"Connexin32-null mice develop demyelinating peripheral neuropathy","volume":"24","author":"Scherer","year":"1998","journal-title":"Glia."},{"issue":"3","key":"10.1007\/s13311-021-01145-z_bib262","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.mcn.2006.05.001","article-title":"The effects of a dominant connexin32 mutant in myelinating Schwann cells","volume":"32","author":"Jeng","year":"2006","journal-title":"Mol Cell Neurosci."},{"issue":"8","key":"10.1007\/s13311-021-01145-z_bib263","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1093\/hmg\/ddy056","article-title":"Intrathecal gene therapy in mouse models expressing CMT1X mutations","volume":"27","author":"Kagiava","year":"2018","journal-title":"Hum Mol Genet."},{"issue":"1","key":"10.1007\/s13311-021-01145-z_bib264","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0006-8993(00)03327-8","article-title":"Functional alterations in gap junction channels formed by mutant forms of connexin 32: evidence for loss of function as a pathogenic mechanism in the X-linked form of Charcot-Marie-Tooth disease","volume":"900","author":"Abrams","year":"2001","journal-title":"Brain Res."},{"issue":"2","key":"10.1007\/s13311-021-01145-z_bib265","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.nbd.2003.11.005","article-title":"Functional analysis of connexin-32 mutants associated with X-linked dominant Charcot-Marie-Tooth disease","volume":"15","author":"Wang","year":"2004","journal-title":"Neurobiol Dis."},{"issue":"9","key":"10.1007\/s13311-021-01145-z_bib266","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1093\/hmg\/ddx064","article-title":"Golgi-retained Cx32 mutants interfere with gene addition therapy for CMT1X","volume":"26","author":"Kyriakoudi","year":"2017","journal-title":"Hum Mol Genet."},{"issue":"6","key":"10.1007\/s13311-021-01145-z_bib267","doi-asserted-by":"crossref","first-page":"3980","DOI":"10.1073\/pnas.261713499","article-title":"Voltage opens unopposed gap junction hemichannels formed by a connexin 32 mutant associated with X-linked Charcot-Marie-Tooth disease","volume":"99","author":"Abrams","year":"2002","journal-title":"Proc Natl Acad Sci U S A."},{"key":"10.1007\/s13311-021-01145-z_bib268","doi-asserted-by":"crossref","first-page":"40166","DOI":"10.1038\/srep40166","article-title":"Loss of Coupling Distinguishes GJB1 Mutations Associated with CNS Manifestations of CMT1X from Those Without CNS Manifestations","volume":"7","author":"Abrams","year":"2017","journal-title":"Sci Rep."},{"issue":"1","key":"10.1007\/s13311-021-01145-z_bib269","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1006\/nbdi.2002.0545","article-title":"Diverse trafficking abnormalities of connexin32 mutants causing CMTX","volume":"11","author":"Yum","year":"2002","journal-title":"Neurobiol Dis."},{"issue":"6","key":"10.1007\/s13311-021-01145-z_bib270","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s100380170064","article-title":"Phenotypes of X-linked Charcot-Marie-Tooth disease and altered trafficking of mutant connexin 32 (GJB1)","volume":"46","author":"Matsuyama","year":"2001","journal-title":"J Hum Genet."},{"issue":"1\u20132","key":"10.1007\/s13311-021-01145-z_bib271","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0304-3940(02)00015-0","article-title":"Macrophage-related demyelination in peripheral nerves of mice deficient in the gap junction protein connexin 32","volume":"320","author":"Kobsar","year":"2002","journal-title":"Neurosci Lett."},{"issue":"Pt 4","key":"10.1007\/s13311-021-01145-z_bib272","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1093\/brain\/awg072","article-title":"Preserved myelin integrity and reduced axonopathy in connexin32-deficient mice lacking the recombination activating gene-1","volume":"126","author":"Kobsar","year":"2003","journal-title":"Brain."},{"issue":"18","key":"10.1007\/s13311-021-01145-z_bib273","doi-asserted-by":"crossref","first-page":"3530","DOI":"10.1093\/hmg\/ddq269","article-title":"Attenuation of MCP-1\/CCL2 expression ameliorates neuropathy in a mouse model for Charcot-Marie-Tooth 1X","volume":"19","author":"Groh","year":"2010","journal-title":"Hum Mol Genet."},{"issue":"2","key":"10.1007\/s13311-021-01145-z_bib274","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.mcn.2007.10.012","article-title":"Monocyte chemoattractant protein-1 is a pathogenic component in a model for a hereditary peripheral neuropathy","volume":"37","author":"Fischer","year":"2008","journal-title":"Mol Cell Neurosci."},{"issue":"6","key":"10.1007\/s13311-021-01145-z_bib275","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1002\/glia.22796","article-title":"CSF-1-activated macrophages are target-directed and essential mediators of Schwann cell dedifferentiation and dysfunction in Cx32-deficient mice","volume":"63","author":"Groh","year":"2015","journal-title":"Glia."},{"issue":"Pt 1","key":"10.1007\/s13311-021-01145-z_bib276","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1093\/brain\/awr283","article-title":"Colony-stimulating factor-1 mediates macrophage-related neural damage in a model for Charcot-Marie-Tooth disease type 1X","volume":"135","author":"Groh","year":"2012","journal-title":"Brain."},{"issue":"3","key":"10.1007\/s13311-021-01145-z_bib277","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1002\/glia.22279","article-title":"Connexin 32 is involved in mitosis","volume":"60","author":"Mones","year":"2012","journal-title":"Glia."},{"key":"10.1007\/s13311-021-01145-z_bib278","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3389\/fnins.2014.00151","article-title":"CamKII inhibitors reduce mitotic instability, connexon anomalies and progression of the in vivo behavioral phenotype in transgenic animals expressing a mutated Gjb1 gene","volume":"8","author":"Mones","year":"2014","journal-title":"Front Neurosci."},{"issue":"2","key":"10.1007\/s13311-021-01145-z_bib279","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/ana.24441","article-title":"Intraneural GJB1 gene delivery improves nerve pathology in a model of X-linked Charcot-Marie-Tooth disease","volume":"78","author":"Sargiannidou","year":"2015","journal-title":"Ann Neurol."},{"issue":"17","key":"10.1007\/s13311-021-01145-z_bib280","doi-asserted-by":"crossref","first-page":"E2421","DOI":"10.1073\/pnas.1522202113","article-title":"Intrathecal gene therapy rescues a model of demyelinating peripheral neuropathy","volume":"113","author":"Kagiava","year":"2016","journal-title":"Proc Natl Acad Sci U S A."},{"key":"10.1007\/s13311-021-01145-z_bib281","doi-asserted-by":"crossref","unstructured":"Kagiava A, Karaiskos C, Richter J, Tryfonos C, Jennings MJ, Heslegrave AJ, et al. AAV9-mediated Schwann cell-targeted gene therapy rescues a model of demyelinating neuropathy. Gene Ther. 2021.","DOI":"10.1038\/s41434-021-00250-0"},{"issue":"21","key":"10.1007\/s13311-021-01145-z_bib282","doi-asserted-by":"crossref","first-page":"3528","DOI":"10.1093\/hmg\/ddz199","article-title":"Gene replacement therapy after neuropathy onset provides therapeutic benefit in a model of CMT1X","volume":"28","author":"Kagiava","year":"2019","journal-title":"Hum Mol Genet."},{"key":"10.1007\/s13311-021-01145-z_bib283","doi-asserted-by":"crossref","unstructured":"Ozes B, Myers M, Moss K, McKinney J, Ridgley A, Chen L, et al. AAV1.NT-3 gene therapy for X-linked Charcot-Marie-Tooth neuropathy type 1. Gene Ther. 2021.","DOI":"10.1038\/s41434-021-00231-3"},{"key":"10.1007\/s13311-021-01145-z_bib284","unstructured":"Azzedine H, Salih MA. SH3TC2-Related Hereditary Motor and Sensory Neuropathy. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Mirzaa G, et al., editors. GeneReviews((R)). Seattle (WA)1993."},{"issue":"3","key":"10.1007\/s13311-021-01145-z_bib285","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/jns.12175","article-title":"Screening for SH3TC2 gene mutations in a series of demyelinating recessive Charcot-Marie-Tooth disease (CMT4)","volume":"21","author":"Piscosquito","year":"2016","journal-title":"J Peripher Nerv Syst."},{"key":"10.1007\/s13311-021-01145-z_bib286","doi-asserted-by":"crossref","unstructured":"Colomer J, Gooding R, Angelicheva D, King RH, Guillen-Navarro E, Parman Y, et al. Clinical spectrum of CMT4C disease in patients homozygous for the p.Arg1109X mutation in SH3TC2. Neuromuscul Disord. 2006;16(7):449\u201353.","DOI":"10.1016\/j.nmd.2006.05.005"},{"key":"10.1007\/s13311-021-01145-z_bib287","doi-asserted-by":"crossref","unstructured":"Gooding R, Colomer J, King R, Angelicheva D, Marns L, Parman Y, et al. A novel Gypsy founder mutation, p.Arg1109X in the CMT4C gene, causes variable peripheral neuropathy phenotypes. J Med Genet. 2005;42(12):e69.","DOI":"10.1136\/jmg.2005.034132"},{"issue":"1","key":"10.1007\/s13311-021-01145-z_bib288","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/jns.12305","article-title":"Mutational screening of the SH3TC2 gene in Greek patients with suspected demyelinating recessive Charcot-Marie-Tooth disease reveals a varied and unusual phenotypic spectrum","volume":"24","author":"Kontogeorgiou","year":"2019","journal-title":"J Peripher Nerv Syst."},{"issue":"3","key":"10.1007\/s13311-021-01145-z_bib289","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1002\/mus.24640","article-title":"Phenotypic variability of CMT4C in a French-Canadian kindred","volume":"52","author":"Varley","year":"2015","journal-title":"Muscle Nerve."},{"issue":"4","key":"10.1007\/s13311-021-01145-z_bib290","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1212\/WNL.48.4.867","article-title":"A clinical, electrophysiologic, neuropathologic, and genetic study of two large Algerian families with an autosomal recessive demyelinating form of Charcot-Marie-Tooth disease","volume":"48","author":"Kessali","year":"1997","journal-title":"Neurology."},{"issue":"1","key":"10.1007\/s13311-021-01145-z_bib291","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/j.1529-8027.2012.00382.x","article-title":"Characteristics of clinical and electrophysiological pattern of Charcot-Marie-Tooth 4C","volume":"17","author":"Yger","year":"2012","journal-title":"J Peripher Nerv Syst."},{"issue":"5","key":"10.1007\/s13311-021-01145-z_bib292","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1086\/379525","article-title":"Mutations in a gene encoding a novel SH3\/TPR domain protein cause autosomal recessive Charcot-Marie-Tooth type 4C neuropathy","volume":"73","author":"Senderek","year":"2003","journal-title":"Am J Hum Genet."},{"issue":"41","key":"10.1007\/s13311-021-01145-z_bib293","doi-asserted-by":"crossref","first-page":"17528","DOI":"10.1073\/pnas.0905523106","article-title":"SH3TC2\/KIAA1985 protein is required for proper myelination and the integrity of the node of Ranvier in the peripheral nervous system","volume":"106","author":"Arnaud","year":"2009","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"7","key":"10.1007\/s13311-021-01145-z_bib294","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1002\/glia.22493","article-title":"Sh3tc2 deficiency affects neuregulin-1\/ErbB signaling","volume":"61","author":"Gouttenoire","year":"2013","journal-title":"Glia."},{"issue":"6","key":"10.1007\/s13311-021-01145-z_bib295","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1093\/hmg\/ddp565","article-title":"Mistargeting of SH3TC2 away from the recycling endosome causes Charcot-Marie-Tooth disease type 4C","volume":"19","author":"Roberts","year":"2010","journal-title":"Hum Mol Genet."},{"issue":"5","key":"10.1007\/s13311-021-01145-z_bib296","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1093\/brain\/awz064","article-title":"Gene replacement therapy in a model of Charcot-Marie-Tooth 4C neuropathy","volume":"142","author":"Schiza","year":"2019","journal-title":"Brain."},{"issue":"6","key":"10.1007\/s13311-021-01145-z_bib297","doi-asserted-by":"crossref","first-page":"e518","DOI":"10.1212\/WNL.0000000000004932","article-title":"Plasma neurofilament light chain concentration in the inherited peripheral neuropathies","volume":"90","author":"Sandelius","year":"2018","journal-title":"Neurology."},{"issue":"5","key":"10.1007\/s13311-021-01145-z_bib298","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1086\/375034","article-title":"Mutations in MTMR13, a new pseudophosphatase homologue of MTMR2 and Sbf1, in two families with an autosomal recessive demyelinating form of Charcot-Marie-Tooth disease associated with early-onset glaucoma","volume":"72","author":"Azzedine","year":"2003","journal-title":"Am J Hum Genet."},{"issue":"1","key":"10.1007\/s13311-021-01145-z_bib299","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/75542","article-title":"Charcot-Marie-Tooth type 4B is caused by mutations in the gene encoding myotubularin-related protein-2","volume":"25","author":"Bolino","year":"2000","journal-title":"Nat Genet."},{"issue":"2","key":"10.1007\/s13311-021-01145-z_bib300","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1212\/WNL.0b013e31829a3421","article-title":"SET binding factor 1 (SBF1) mutation causes Charcot-Marie-Tooth disease type 4B3","volume":"81","author":"Nakhro","year":"2013","journal-title":"Neurology."},{"issue":"7149","key":"10.1007\/s13311-021-01145-z_bib301","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/nature05876","article-title":"Mutation of FIG4 causes neurodegeneration in the pale tremor mouse and patients with CMT4J","volume":"448","author":"Chow","year":"2007","journal-title":"Nature."},{"issue":"2","key":"10.1007\/s13311-021-01145-z_bib302","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1582-4934.2009.00967.x","article-title":"The CMT4B disease-causing proteins MTMR2 and MTMR13\/SBF2 regulate AKT signalling","volume":"15","author":"Berger","year":"2011","journal-title":"J Cell Mol Med."},{"issue":"1","key":"10.1007\/s13311-021-01145-z_bib303","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/ana.25500","article-title":"A multicenter retrospective study of charcot-marie-tooth disease type 4B (CMT4B) associated with mutations in myotubularin-related proteins (MTMRs)","volume":"86","author":"Pareyson","year":"2019","journal-title":"Ann Neurol."},{"key":"10.1007\/s13311-021-01145-z_bib304","doi-asserted-by":"crossref","unstructured":"Vaccari I, Dina G, Tronchere H, Kaufman E, Chicanne G, Cerri F, et al. Genetic interaction between MTMR2 and FIG4 phospholipid phosphatases involved in Charcot-Marie-Tooth neuropathies. PLoS Genet. 2011;7(10):e1002319.","DOI":"10.1371\/journal.pgen.1002319"},{"issue":"5","key":"10.1007\/s13311-021-01145-z_bib305","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.neuron.2005.08.017","article-title":"Neuregulin-1 type III determines the ensheathment fate of axons","volume":"47","author":"Taveggia","year":"2005","journal-title":"Neuron."},{"issue":"12","key":"10.1007\/s13311-021-01145-z_bib306","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.15252\/emmm.201606349","article-title":"Niacin-mediated Tace activation ameliorates CMT neuropathies with focal hypermyelination","volume":"8","author":"Bolino","year":"2016","journal-title":"EMBO Mol Med."},{"key":"10.1007\/s13311-021-01145-z_bib307","doi-asserted-by":"crossref","unstructured":"Lenk GM, Ferguson CJ, Chow CY, Jin N, Jones JM, Grant AE, et al. Pathogenic mechanism of the FIG4 mutation responsible for Charcot-Marie-Tooth disease CMT4J. PLoS Genet. 2011;7(6):e1002104.","DOI":"10.1371\/journal.pgen.1002104"},{"issue":"Pt 8","key":"10.1007\/s13311-021-01145-z_bib308","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1093\/brain\/awn114","article-title":"Mutation of FIG4 causes a rapidly progressive, asymmetric neuronal degeneration","volume":"131","author":"Zhang","year":"2008","journal-title":"Brain."},{"issue":"Pt 7","key":"10.1007\/s13311-021-01145-z_bib309","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1093\/brain\/awr148","article-title":"Distinctive genetic and clinical features of CMT4J: a severe neuropathy caused by mutations in the PI(3,5)P(2) phosphatase FIG4","volume":"134","author":"Nicholson","year":"2011","journal-title":"Brain."},{"issue":"4","key":"10.1007\/s13311-021-01145-z_bib310","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1002\/ana.25198","article-title":"Myelin abnormality in Charcot-Marie-Tooth type 4J recapitulates features of acquired demyelination","volume":"83","author":"Hu","year":"2018","journal-title":"Ann Neurol."},{"key":"10.1007\/s13311-021-01145-z_bib311","doi-asserted-by":"crossref","unstructured":"Presa M, Bailey RM, Davis C, Murphy T, Cook J, Walls R, et al. AAV9-mediated FIG4 delivery prolongs life span in Charcot Marie Tooth disease type 4J mouse model. J Clin Invest. 2021.","DOI":"10.1172\/JCI137159"},{"issue":"16","key":"10.1007\/s13311-021-01145-z_bib312","doi-asserted-by":"crossref","first-page":"3525","DOI":"10.1093\/hmg\/dds179","article-title":"Neuronal expression of Fig4 is both necessary and sufficient to prevent spongiform neurodegeneration","volume":"21","author":"Ferguson","year":"2012","journal-title":"Hum Mol Genet."},{"issue":"17","key":"10.1007\/s13311-021-01145-z_bib313","doi-asserted-by":"crossref","first-page":"6801","DOI":"10.1523\/JNEUROSCI.4442-14.2015","article-title":"Reactivation of Lysosomal Ca2+ Efflux Rescues Abnormal Lysosomal Storage in FIG4-Deficient Cells","volume":"35","author":"Zou","year":"2015","journal-title":"J Neurosci."},{"issue":"6","key":"10.1007\/s13311-021-01145-z_bib314","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.nmd.2006.03.008","article-title":"136th ENMC International Workshop: Charcot-Marie-Tooth disease type 1A (CMT1A)8\u201310 April 2005, Naarden","volume":"16","author":"Reilly","year":"2006","journal-title":"The Netherlands. Neuromuscul Disord."},{"issue":"3","key":"10.1007\/s13311-021-01145-z_bib315","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1529-8027.2011.00350.x","article-title":"Reliability of the CMT neuropathy score (second version) in Charcot-Marie-Tooth disease","volume":"16","author":"Murphy","year":"2011","journal-title":"J Peripher Nerv Syst."},{"issue":"3","key":"10.1007\/s13311-021-01145-z_bib316","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/jns.12084","article-title":"Psychometrics evaluation of Charcot-Marie-Tooth Neuropathy Score (CMTNSv2) second version, using Rasch analysis","volume":"19","author":"Sadjadi","year":"2014","journal-title":"J Peripher Nerv Syst."},{"issue":"9","key":"10.1007\/s13311-021-01145-z_bib317","doi-asserted-by":"crossref","first-page":"e884","DOI":"10.1212\/WNL.0000000000009035","article-title":"A longitudinal study of CMT1A using Rasch analysis based CMT neuropathy and examination scores","volume":"94","author":"Fridman","year":"2020","journal-title":"Neurology."},{"issue":"5","key":"10.1007\/s13311-021-01145-z_bib318","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1002\/ana.23572","article-title":"Validation of the Charcot-Marie-Tooth disease pediatric scale as an outcome measure of disability","volume":"71","author":"Burns","year":"2012","journal-title":"Ann Neurol."},{"issue":"12","key":"10.1007\/s13311-021-01145-z_bib319","doi-asserted-by":"crossref","first-page":"3319","DOI":"10.1093\/brain\/awy280","article-title":"Development and validation of the Charcot-Marie-Tooth Disease Infant Scale","volume":"141","author":"Mandarakas","year":"2018","journal-title":"Brain."},{"issue":"2","key":"10.1007\/s13311-021-01145-z_bib320","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/ana.25966","article-title":"Development and Validation of the Pediatric Charcot-Marie-Tooth Disease Quality of Life Outcome Measure","volume":"89","author":"Ramchandren","year":"2021","journal-title":"Ann Neurol."},{"issue":"1","key":"10.1007\/s13311-021-01145-z_bib321","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S1474-4422(15)00242-2","article-title":"MRI biomarker assessment of neuromuscular disease progression: a prospective observational cohort study","volume":"15","author":"Morrow","year":"2016","journal-title":"Lancet Neurol."},{"issue":"12","key":"10.1007\/s13311-021-01145-z_bib322","doi-asserted-by":"crossref","first-page":"e1125","DOI":"10.1212\/WNL.0000000000006214","article-title":"Validation of MRC Centre MRI calf muscle fat fraction protocol as an outcome measure in CMT1A","volume":"91","author":"Morrow","year":"2018","journal-title":"Neurology."},{"issue":"1","key":"10.1007\/s13311-021-01145-z_bib323","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/acn3.50965","article-title":"Transmembrane protease serine 5: a novel Schwann cell plasma marker for CMT1A","volume":"7","author":"Wang","year":"2020","journal-title":"Ann Clin Transl Neurol."},{"issue":"11","key":"10.1007\/s13311-021-01145-z_bib324","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1136\/jnnp-2017-315721","article-title":"Biomarkers predict outcome in Charcot-Marie-Tooth disease 1A","volume":"88","author":"Fledrich","year":"2017","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"10.1007\/s13311-021-01145-z_bib325","doi-asserted-by":"crossref","unstructured":"Hartmannsberger B, Doppler K, Stauber J, Schlotter-Weigel B, Young P, Sereda MW, et al. Intraepidermal nerve fibre density as biomarker in Charcot-Marie-Tooth disease type 1A. Brain Commun. 2020;2(1):fcaa012.","DOI":"10.1093\/braincomms\/fcaa012"}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-021-01145-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13311-021-01145-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923007018?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923007018?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-021-01145-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T06:43:31Z","timestamp":1761806611000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878747923007018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":325,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["S1878747923007018"],"URL":"https:\/\/doi.org\/10.1007\/s13311-021-01145-z","relation":{},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mechanisms and Treatments in Demyelinating CMT","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s13311-021-01145-z","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2021 The American Society for Experimental NeuroTherapeutics, Inc. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}